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A Legacy of Discovery

A NOTE FROM ROSS HALL

Building a Community
of Knowledge and Skill

I

t has been said that the most important
thing that we do as a university is create alumni who graduate with their new
knowledge and skills prepared to make a
difference in the world.
The GW School of Medicine and Health
Sciences (SMHS) has generated thousands of
outstanding and influential physicians, health
professionals, and scientists who have touched
millions of lives and thousands of communities.
Over the past several months, I have been
honored to meet with our Medicine and Health
Sciences alumni in multiple cities across the
country. Without question, the most common
thing I hear from our alumni is that they believe
they were better prepared than their non-GW
peers as they embarked upon their health careers.
Our alumni are remarkably proud of GW and
grateful for the education, training, and opportunities afforded to them.

SMHS alumni are eager to rattle off
the names of their classmates who are
accomplishing great things. Our alumni are
internationally recognized for their cuttingedge basic science and clinical research, their
advanced clinical practices, their leadership
in professional and scientific societies, their
service to their communities and commitment
to philanthropy, and their reputations
as distinguished physicians and health
professionals.
Our alumni have discovered new treatments
and medical devices, made important
contributions to medical and scientific literature,
influenced legislation and health policy, and
led complex organizations. They are a valuable
resource for the communities in which they
live and work, for each other, as well as for our
current and future students.
These achievements and contributions are
central to the overall reputation of SMHS.
We look to our alumni to serve as a built-in
community of outstanding role models and
mentors for our students. We also ask our
alumni to contribute to the advancement of our
school and society.
Please email (smhsalumni@email.gwu.edu)
and keep us informed of your current projects,
employment, appointments, and latest accomplishments. Your classmates, the GW medical
community, and I want to hear about the great
things you are doing.

Best wishes,

JEFFREY S. AKMAN, M.D. ’81, G.M.E. ’85
INTERIM VICE PRESIDENT FOR HEALTH AFFAIRS
AND DEAN, SCHOOL OF MEDICINE
AND HEALTH SCIENCES

George Washington University
W. RUSSELL RAMSEY, B.B.A. ’81
Chair, Board of Trustees
STEVEN KNAPP, PH.D.
President

9

The School of Medicine
and Health Sciences
JEFFREY S. AKMAN,
M.D. ’81, G.M.E. ’85
Interim Vice President
for Health Affairs and Dean,
School of Medicine and Health
Sciences
DENNIS NARANGO
Associate Dean of the School
of Medicine and Health Sciences
and Associate Vice President
of GW Medicine Development
and Alumni Relations

Medicine + Health
EXECUTIVE EDITOR
Anne Banner
MANAGING EDITOR
Thomas Kohout

CONTRIBUTING WRITERS
Steven Goldstein
and Kristin Hubing

Features

23 Matter Over Mind

COVER STORY

		 Researchers identify
		 gene involved in white
		 matter development

20 A Legacy of Discovery

		 By Steve Goldstein

		Michael I. Bukrinsky, M.D., Ph.D.,
interim chair of the Department of
Microbiology, Immunology, and
Tropical Medicine, fled the Soviet
Union to follow his research

Medicine + Health
is published by the SMHS
Office of Communications
and Marketing
2300 Eye Street, N.W.
Ross Hall, Suite 313B
Washington, D.C. 20037
Telephone: (202) 994-8110
editor@gwu.edu
www.smhs.gwumc.edu
Please download a mobile app
to scan the QR code below and
follow the School of Medicine and
Health Sciences on Facebook.

10%

FSC

nrydedw

,i

		Rising fourth-year Daniel
O’Neill balances HIV
activism with life as an
M.D./M.P.H. degree student

		Curriculum revamp
emphasizes patient care

10 Custom Tailoring

26 W here Opportunities

		GW Pharmacogenomics program
explores fashioning
individualized drug therapies

12 T he Art of Healing

		By Thomas Kohout

		Retired faculty members draw
on decades of experience to teach
the principles of practice

		By Steve Goldstein

Lead
		 By Thomas Kohout

		Rep. Donna Christensen,
M.D. ’70, follows the path
from St. Croix to Capitol Hill

28 Well Integrated

in Health
		 By Thomas Kohout

14 B uilding Sudan

		John and Katherine Pan turn
a long-standing association
with GW School of Medicine
and Health Sciences into a
major commitment

		Glenn Geelhoed, M.D., unites the
warring tribes of South Sudan
around a marathon team

Departments

on the Run
		 By Steve Goldstein

		Students examine their
genomes in an innovative course
d^

		 By Steve Goldstein

		 Resident Mary Tanski, M.D.
		 keeps one step ahead of
		 the next emergency

Gets Personal
		By Anna Miller

wfiMr

24 Action Unlimited

25 Lead Runner

18 W hen Class

Mixed Sources

		 By Anna Miller

A Medical Education
Makeover
		 By Anna Miller

		By Steve Goldstein

ART DIRECTOR
Karin Palmquist

20

CONTENTS

9

ASSISTANT EDITOR
Anna Miller

14

2

Making the Rounds

29

Class Notes

33

Faculty News

Additional content
is available online
wherever you see
this symbol

MAKING THE ROUNDS
A Day of Service
Rather than spending the day before
residency Match Day pacing, nail-biting, and going over last-minute “whatif” scenarios, a group of fourth-year
GW medical students redirected that
pre-match nervous energy back into
MICHAEL LEONG

the community.
More than 60 budding physicians helped to renovate what might
become a safe house for Washington, D.C. residents in need, during

Match Madness
Raphael Karkowsky, a fourth-year medical student in the George Washington

the Gold Humanism Honor Society’s
(GHHS) Annual Day of Service, on
March 15.
“Each year, GHHS members vote

University School of Medicine and Health Sciences (SMHS), wasn’t sure if it

on how they’d like to spend their day

was nerves or just a sugar rush from brunch. Whatever it was, he knew his

of service,” explained Rahul Vanjani, a

heartbeat was picking up its pace.

GHHS member. “This year, we chose

Like thousands of other fourth-year medical students across the country,

something that we believed character-

including his twin brother at the University of Maryland School of Medicine,

ized our class and the type of project

Karkowski was anticipating what many call the most pivotal moment of their

we wanted to pursue: a focus on the

medical education: Match Day.

underserved and the integration of

Held on March 16 this year, nearly 16,000 medical students nationwide
simultaneously received and opened envelopes from the National Residency

GW into the D.C. community.”
The event, organized by GHHS

Matching Program revealing the institution where they will be spending at least

and open to all fourth-year medical

the next three years of their professional lives. At GW, students, faculty, family,

students, linked GW students with

and friends all gathered in Ross Hall to celebrate the occasion.

Temporary Emergency Residential

“You matched at some incredible places across the United States of America

Resource Institute for Families in

— including the George Washington University,” said Yolanda Haywood, M.D.,

Crisis (TERRIFIC, Inc.), a non-profit

assistant dean for Student and Curricular Affairs and associate professor of

housing and human service organi-

Emergency Medicine at SMHS, at the ceremony.

zation serving families in crisis. GW

When the clock struck noon, the students — who were dressed in t-shirts

volunteers spent the day painting the

and accessories signifying their intended specialty — tore into their envelopes.

interior of a three-story house as part

Cheers, tears, and champagne toasts ensued.

of a renovation project.

Across the room, Karkowsky, who matched to an internal medicine residency

A highlight of the day, according to

at Thomas Jefferson University, tried to reach his twin brother William. “I’m

Joanie Brumbaugh, a GHHS member

really happy,” he said. His brother matched in internal medicine at the University

and Day of Service organizer, came

of Chicago.

when the founder of TERRIFIC, Inc.

Overall, SMHS students matched with many of the leading institutions

visited the GW team on site. “She was

across the country, including Einstein/Beth Israel Medical Center in New York

moved to tears and thanked us for

City, the University of Chicago Medical Center, Massachusetts General Hospital

providing a service that her organi-

in Boston, and the Baylor College of Medicine in Houston. Fourteen students

zation couldn’t afford,” said Brum-

will continue their training here at GW.

baugh. “She was so excited about the

To see the complete list of this year’s SMHS Match Day schools, visit
www.gwumc.edu/matchday2012. n
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potential of that house to be a place
of refuge and hope.” n

A Voice for Medical Students
While her classmates were anxiously waiting during the Match Day
countdown March 17, Elizabeth
Wiley, J.D., M.P.H., a fourth-year
medical student at the George
Washington University School of
Medicine and Health Sciences
(SMHS), was touring Ghana, where
she served as a delegate at the 61st
General Assembly March Meeting
MICHAEL LEONG

of the International Federation of
Medical Students’ Associations.
But Wiley was just as nervous
as her peers back in the United
States. She too was awaiting big
news about her future, specifically, whether or not she had been
elected to serve as the national president of the American Medical Student
Association (AMSA), the nation’s oldest and largest independent association for
physicians-in-training.
“When the election results were
announced, I was elated — and
relieved!” said Wiley, who will delay
residency for a year during her term
as president. “It’s an honor to lead an
exceptional organization that inspires
a community of future physicians
through education and advocacy.”
Wiley is the first GW student to
hold this position — a full-time job
that involves chairing AMSA’s Board

“Throughout medical school,
I’ve had unparalleled
opportunities to integrate my
passion for health policy and
advocacy into my training.”
Elizabeth Wiley, J.D., M.P.H

of Trustees, maintaining alliances with
other organizations, and visiting AMSA chapters around the country — but it’s
GW that Wiley credits for priming her for the responsibility.
“Throughout medical school, I’ve had unparalleled opportunities to integrate
my passion for health policy and advocacy into my training,” she said. Through
SMHS’s track in Health Policy, Wiley even worked with professors Fitzhugh Mullan, M.D., M.P.H., Murdock Head Professor of Medicine and Health Policy, and
Candice Chen, M.D., M.P.H., assistant research professor of Health Policy, in
GW’s School of Public Health and Health Services, to draft legislative language
that ended up in the Patient Protection and Affordable Care Act.
“I don’t think any other medical student in the country is able to say that,”
said Wiley. “And it’s thanks to GW that I had that opportunity.”
Throughout her term, Wiley hopes to advocate for increased access to health
care for all Americans, address the growing problem of student debt, and bring
more political awareness to HIV/AIDS and reproductive justice.
“I want to be a voice for medical students in the upcoming election and on
Capitol Hill,” she said. n

The Marriage of
Medicine and Machine
Already one of the largest robotic
surgery programs in the country,
the George Washington University
Hospital (GW Hospital) is taking steps
to become the regional leader among
multi-specialty robotic observation
centers. With the addition of two new
robots, GW Hospital is the first in the
Washington/Baltimore area offering
daVinci Si robots with dual console capability and fluorescence imaging and
skills simulation for surgical training.
Paired with the dual console system, two surgeons are able to collaborate during a procedure and exchange
control of the instrument arms and
endoscope. The console also features
built-in intercoms to facilitate communications between surgeons while both
are seated at consoles.
“The advantages of robot-assisted
surgery are significant,” says Thomas
W. Jarrett, professor of Urology at the
School of Medicine and Health Sciences, and chair of the Department
of Urology at the GW Medical Faculty
Associates. “Incisions are smaller,
patients may experience less pain,
they often do not need strong narcotic
pain medication, and they can resume
their normal daily activities in about
half the time as they can with traditional surgery.”
In 2004, GW Hospital became the
first in the area to have the daVinci
system. Since then, GW surgeons
have performed more than 2,500
robotic procedures. GW’s surgical
team was the first in the area to use
the daVinci for colectomies, and in
January, Fredrick Brody, M.D., director
of Minimally Invasive Surgery, and Paul
Lin, M.D., vice chair of the Department
of Surgery and Chief of General and
Hepatopancreatic Surgery, performed
the region’s first robotic-assisted laparoscopic Whipple procedure. n
M E D I C I N E + H E A LT H
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An architectural rendering of the new interior space of Ross Hall.

Facilities Improvement to
Build a Route Out of Poverty
At the core of the mission of GW’s School of Medicine and Health Sciences
(SMHS), faculty and physicians strive to improve the health and well-being of
the local, national, and global communities. With the aide of a $15 million grant
awarded to SMHS from the National Institutes of Health (NIH) through the
American Recovery and Reinvestment Act (ARRA), as well as additional support
from the school, GW is embracing this ideal and building a new research center to
address Neglected Diseases of Poverty. These diseases, which include Neglected
Infections of Poverty and Neglected Tropical Diseases, are illnesses prevalent
among the world’s poorest and most desperate populations, affecting billions of
people, especially children. Often these populations are left too sick to work or go
to school — contributing to a perpetual cycle of poverty.
GW’s new Research Center for Neglected Diseases of Poverty will be equipped
with state-of-the-art laboratories where researchers will be empowered to identify
innovative ways to focus on prevention and treatments for people who are afflicted
with these diseases. GW’s biotechnology capacity will expand through new equipment and increased efficiencies within the lab space, creating more collaborative
learning spaces for students, laboratory personnel, and faculty. Additional research
will be conducted at the facility to translate basic science discoveries into new products. The Center will provide the space and facilities to enable SMHS to recruit
new faculty and staff and expand the mission of the Center.
To accommodate the new center, the fifth and sixth floors of Ross Hall will be
fully renovated to provide new laboratory space and an exterior-egress stairwell
4 smhs.gwumc.edu • S P R I N G 2 0 1 2

will be constructed on the northwest
side of the building to provide better
access inside Ross Hall and an additional route out of the building. The
project will be managed by GW and
facilitated in close collaboration with
the NIH to meet the requirements of
ARRA funding. Clark Construction
will implement the work. The project
will begin in May 2012 and is slated for
completion in the fall of 2013.
Concurrent with the Research
Center for Neglected Diseases project
there will be upgrades to the Ross Hall
central utility plant (CUP). Renovations to the CUP will support Ross Hall
infrastructure as well as provide utilities
for the Science and Engineering Hall.
For more information about the
Ross Hall construction project, visit
www.gwumc.edu/
rosshallconstruction. n

GW Symposium Attracts Global
Experts in Thymosins Research
There aren’t many researchers in the world who can call

of the select community of thymosin researchers. In the

themselves experts on Thymosins. The small, naturally

mid-1960s, Goldstein discovered thymosins, first isolating

occurring proteins that hold diverse biological roles includ-

the hormone-like peptides.

ing the stimulation or suppression of the body’s immune

Since then, a synthetic version, Thymosin α1, has been

response were first identified more than 40 years ago, but

tested in lung cancer patients, used in treatments for hepa-

only now are their powers being fully explored. But among

titis B and C, and used as therapy to boost immune system

the world’s leading scientists investigating thymosins, most

responses in patients around the world.

were on GW’s campus for the Third International Symposium on Thymosins in Health and Disease, March 14–16.
Researchers from Europe, Asia, and North America presented their work on the impact of two thymosins, α1 and
β4, on cardiovascular disease; neurodegenerative diseases

“We still need to define the full therapeutic potential of
these thymic peptides and to further define the physiological role of the thymus in health and disease,” explained
Goldstein.
The three-day conference culminated with the presen-

and brain trauma; wound healing; immunomodulation,

tation of the 2012 Abraham White Scientific, Humanitarian,

infectious diseases, and tolerance; cancer; and vaccines.

and Public Service Awards, honoring three individuals for

The symposium was co-hosted by Allan Goldstein,

their unique contributions to science, medicine, and the

Ph.D., professor and Chair Emeritus, of GW’s School of

global community: Deepak Srivastava, M.D., professor of

Medicine and Health Sciences Department of Biochemistry

Pediatrics and director of the Gladstone Institute of Cardio-

and Molecular Biology, and Enrico Garaci, M.D., president

vascular Disease; Luigina Romani, M.D., Ph.D., professor

of the Instituto Superiore di Sanita and professor of Micro-

of Microbiology at the University of Perugia, Perugia, Italy;

biology at the University of Rome “Tor Vergata.”

and Margaret Stern, chair of The Michael Stern Parkinson’s

More than just responsible for launching the international conference, the pair are considered founding members

Research Foundation, who received the award on behalf of
her father, Michael. n

From Curiosity to Cure

are broken down by cell enzymes.

has highly specific processes to

During his lecture, Ciechanover

replace the poor quality proteins with

Rakesh Kumar, Ph.D., Catharine Birch

recalled the road to his discovery.

fresher ones. If these processes are

and William McCormick Chair of the

When he first started out, he said,

imperfect, it can cause diseases such

department of Biochemistry and Mo-

“people were mesmerized by tran-

as cystic fibrosis.

lecular Biology in the George Wash-

scription,” the process by which DNA

ington University’s School of Medicine

is converted to RNA. “People didn’t

growing emphasis on translational

and Health Sciences (SMHS), says the

care about destruction. They were

research, moving basic science dis-

aim of his department’s Nobel Laure-

fascinated with construction.”

coveries into therapeutics. Although

ate lecture series “is to bring the best

But Ciechanover wasn’t like most

Ciechanover questioned the

his discovery has since led to the

people in the world to Washington,

people. He was interested in destruc-

development of drug therapies, such

D.C., and to GW.”

tion, in particular, the degradation of

as those used to treat neurodegenera-

proteins in cells. “We are replacing

tive disorders, Ciechanover said his

February, when Nobel Laureate Aaron

every molecule in our body, and yet,

goal was never therapy-driven.

Ciechanover, M.D., Ph.D., traveled

we remain the same,” he marveled.

That lofty goal was achieved in

“The whole thing evolved out of a
curiosity to answer an unanswered

from his home in Israel to GW’s Foggy

Intracellular protein degradation is

Bottom campus to deliver the depart-

important for “quality control” issues,

biological question — not to develop

ment’s second Nobel Laureate lecture.

Ciechanover explained. In the same

any drug,” he said. “I think it’s a les-

way that meat in the refrigerator goes

son. It shows you that curiosity leads

in Chemistry in 2004 with two other

bad, the quality of the protein in our

you to unexpected growth at the

scientists for describing how proteins

cells diminishes over time. The body

end.” n

Ciechanover won the Nobel Prize

M E D I C I N E + H E A LT H

5

MAKING THE ROUNDS

Translating Research to the Community
MICHAEL LEONG

From the diagnosis of acute upper
gastrointestinal hemorrhage to the
epidemiology of dengue fever in St.
Lucia, students, faculty, and residents
in GW’s School of Medicine and
Health Sciences tackle not only the
most academically interesting subjects
in health care, but also the topics with
the greatest influence on the health and
well-being of people around the world.
These projects and more than 300
others were on display at GW’s 17th
Annual Health and Medicine Research
Day, March 28.
“Health and Medicine Research
Day is always an exciting day,” said
Jeff Akman, M.D., ’81, G.M.E. ’85,
interim vice president for Health Affairs
and dean of SMHS, who delivered
welcoming remarks at the Jack Morton

Following her GW Research Day address, Lisa Guay-Woodford, M.D., director of the
Clinical and Translational Science Institute at Children’s National Medical Center, at right,
toured the poster session area.

special skills that really are encompassed across the spectrum of our
enterprise.”
During her speech,
Guay-Woodford, a
pediatric nephrologist, described recent
scientific advances
in polycystic kidney
disease and used
the condition as an
allegory for successful
translational research.
Fifty percent
of patients with
polycystic kidney
disease, a genetic
kidney disorder, progress to end-stage
renal disease, said Guay-Woodford.
One of the goals of her research is to
understand why the other half doesn’t
progress and then to use that knowledge
to help prevent disease progression in
all patients.
“We are getting close to targeted
therapies that will weaken the progression of the disease,” she said. “If we
could change the natural history of the
disease so that no one suffers end-stage
renal disease, that would be a major
clinical advance.”

“Translational research knits us together as

a research community, because translational
research is a team sport and it requires

people with special skills that really are

encompassed across the spectrum of our
enterprise.”

Lisa Guay-Woodford, M.D.
Auditorium. “It enables us to truly
learn about the expanding scientific
enterprise that’s happening right here
within our own institution.”
The annual event kicked off with a
keynote address delivered by Lisa GuayWoodford, M.D., director of the Clinical and Translational Science Institute
at Children’s National Medical Center
(see p. 7).
“Translational research knits us
together as a research community,” she
said, “because translational research is
a team sport and it requires people with
6 smhs.gwumc.edu • S P R I N G 2 0 1 2

In the afternoon, the spotlight
turned from experienced researchers
to aspiring ones, as students presented
their projects on posters that filled
the Marvin Center. They shared what
they’ve learned with each other and
responded to rapid questioning from
faculty members who judged their work.
At the award ceremony that
followed, winners of the oral competition delivered short presentations about
their research. Rakesh Kumar, Ph.D.,
professor and Catharine Birch and
William McCormick Chair of SMHS’s
Department of Biochemistry, and
Jeanny Aragon-Ching, M.D., assistant
professor in SMHS’s Department of
Medicine and a member of the Division
of Hematology and Oncology at The
GW Medical Faculty Associates, were
awarded the 2011 Elaine H. Snyder
Cancer Research Award. John N. van
den Anker, M.D., Ph.D., professor of
Pediatrics and of Pharmacology and
Physiology at SMHS received the 2012
Distinguished Researcher Award
(see p. 34).
For a complete list of the winners of
the oral competition and poster presentations, visit www.gwumc.edu/
researchday2012. n

New Leaders
in GW Medicine

Digital Transcriptome Discovery Could Lead
to Targeted Therapies for Breast Cancer

The George Washington University School of

Researchers in GW’s School of Medicine and Health Sciences (SMHS)

Medicine and Health Sciences and its partnering

Department of Biochemistry and Molecular Biology, published a

institutions the George Washington University

first-of-its-kind study into the use of mRNA sequencing to look at

Hospital (GW Hospital) and Children’s National

the expression of the genome for three types of breast cancer at an

Medical Center (Children’s National), recently

unprecedented resolution. The study, titled “Transcriptomic landscape

added key new personnel to their executive

of breast cancer through mRNA sequencing,” was published in the

teams.

Feb. 14 edition of the journal Scientific Reports, a new open access

Lisa Guay-Woodford, M.D., Ph.D., joined
Children’s National as the new director of the
Center for Clinical and Community Research
and the Principal Investigator of the Clinical and
Translational Science Institute (CTSI). Trained
and certified as a pediatric nephrologist, GuayWoodford will lead the CTSI’s mission to speed
the development of new treatments by making
it easier for basic science discoveries to move
from the laboratory to clinical care. The CTSI
was formed out of a five-year, $20 million Clinical
and Translational Science Award (CTSA) from
the National Institutes of Health. Guay-Woodford
comes to Children’s National from the University
of Alabama at Birmingham (UAB) where she was
the principal investigator of UAB’s CTSA.
GW Alumnus Barry A. Wolfman, M.S. ’84,
recently joined GW Hospital to serve as CEO
and Managing Director. In his 27-year career
in health care, Wolfman has served as a multisystem senior executive, hospital CEO, and

journal from the publishers of Nature for large-volume data.
Breast cancer is the leading cause of cancer death among women,
accounting for about 23 percent of the total cancer cases and about
14 percent of the cancer deaths worldwide. An obstacle hindering
the translation of gene expression research into patient treatments is
the highly individualized nature of the disease. One avenue past this
roadblock is gaining a deeper insight into the transcriptional regulatory
machinery responsible for the cellular changes that result in breast
cancer.
The GW team, led by senior author Rakesh Kumar, Ph.D., GW’s
Catharine Birch and William McCormick Chair of the department of
Biochemistry and Molecular Biology, contrasted the gene expression patterns of 17 patients with three different types of breast cancer
to identify biologically relevant, therapeutically important, targets in
breast cancer. The researchers defined a comprehensive digital transcriptome — RNA molecules found in a population of cells — and performed extensive comparative analysis of the three groups of breast
cancer. Their research yielded a staggering 1.2 billion reads at various
levels of the transcriptional process.
“For the first time, mRNA sequencing of human breast cancer
tissues provides knowledge on central transcriptional regulatory elements, demonstrating unexplored niches that could change the way

medical school board member. His most recent

breast cancer is understood,” said lead author Jeyanthy Eswaran,

position was with Providence Health & Services

Ph.D., director of GW’s McCormick Genomic and Proteomic Center.

as chief executive at Providence Saint Joseph
Medical Center in Burbank, Calif.
Dennis Narango was selected as associate

While most research today is focused on preselected genes, the
GW team used an unbiased approach to come up with an original
snapshot of the breast cancer transcriptome. The team is working to

dean of the School of Medicine and Health

gain a better understanding of the fundamental occurrences orches-

Sciences (SMHS) and associate vice president

trating the events that lead to a patient suffering from breast cancer.

of GW Medicine Development and Alumni

“From the ongoing work in the laboratory, it is clear that this study

Relations. In his role, Narango leads the

has implications beyond the current digital transcriptome of breast

development and alumni affairs team in support

cancer, as the team is actively characterizing novel mutations in pro-

of SMHS and directs all aspects of fundraising

tein-coding genes and other elements of human genome that might be

and capital development for GW Medicine. He

relevant in breast cancer,” said Kumar. The work, he said, may influ-

comes to GW from the University of Maryland

ence breast cancer genomics, the transcriptional regulation of cancer,

School of Medicine where he was the associate

and help build new biologic pathways in breast cancer.

dean for development and chief development
officer. n

For more information about ongoing research in the Department of
Biochemistry and Molecular Biology, visit gwumc.edu/smhs/
biochemistry/support.html. n
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tion for physicians, nurses, occupational and physical therapists, physician assistants, and other clinicians who provide
care for the over-65 crowd — a population that’s growing by
the second.
“There are gaps between geriatric and palliative care
education,” says Lunsford. But because most people over
the age of 65 are dealing with chronic health conditions,
closing those gaps is more critical than ever before.

“The goal is to achieve quality of life that gives
the person the opportunity to continue to grow
and develop as a person.”
Beverly Lunsford, Ph.D., R.N.

Faculty Integrate
Palliative Care into
Geriatrics Education
There’s no good reason to fear old age, says Beverly Lunsford, Ph.D., R.N., director of the Center for Aging Health
and Humanities in GW’s School of Medicine and Health
Sciences (SMHS), and associate research professor in the
George Washington University School of Nursing (SON).
Older adults live active and vibrant lives, she says. They
continue to grow, develop, and seek meaning and purpose
in their lives. They are not the sum of their broken parts;
they are individuals with potential — and they deserve to be
treated as such.
“I want to change people’s notion of the older adult from
someone who’s just a health problem to a person with creative potential,” says Lunsford. And thanks to a three-year,
$500,000 grant from the Health Resources and Services
Administration (HRSA), she is already working toward this
goal.
The award, which is in the final year of its original funding, supports the Geriatric Education Utilizing a Palliative
Care Framework (GEPaC) project, a multi-disciplinary effort
aimed at increasing access to high-quality geriatric educa8 smhs.gwumc.edu • S P R I N G 2 0 1 2

Through the GEPaC curriculum, aspiring health care
professionals will learn how to manage disease in a way that
promotes optimal functioning and a high quality of life. The
modules focus on person-centered care, communication,
interdisciplinary collaboration, quality of life, and multidimensional aspects of aging.
“The goal is not curing,” says Lunsford. “The goal is to
achieve quality of life that gives the person the opportunity
to continue to grow and develop as a person.”
Lunsford credits her interdisciplinary team of colleagues
— including Philip Blatt, P.T., Ph.D., assistant professor
of Health Care Sciences at SMHS; Cheryl Arenella M.D.,
M.P.H, a cancer education specialist in Virginia; Jacqueline
Barnett, M.S.H.S., P.A.-C., assistant professor of Health
Care Sciences; Elizabeth Cobbs, M.D., associate professor of Medicine at SMHS; Mary Corcoran, Ph.D., associate
dean of Faculty Development for Health Care Sciences at
SMHS; Jean Johnson, Ph.D., R.N., dean of SON; Laurie
Lyons, instructional designer at SMHS; Laurie Posey, Ed.D.,
assistant professor at SON; and Paul Tschudi, Ed.S., visiting
assistant professor of Health Care Sciences at SMHS —
with helping make the project accessible to a wide variety of
health professions
Once complete, the collaboration between SON, SMHS,
Shenandoah University, and the National Hospice and
Palliative Care Organization will implement the project in traditional classroom, online classroom, and online continuing
education settings.
“There is a real hunger for geriatrics education,” says
Lunsford. “If we can teach it from a palliative perspective,
we can better manage disease, improve quality of life, support the patient and family, and lower health care costs. It’s
a win-win situation.” n

HOLGER THOSS

A Medical Education Makeover
NEW CURRICULUM REVAMP EMPHASIZES PATIENT CARE

Two years of basic sciences, two years of clinical rotations. That’s the standard
medical education curriculum, a formula that’s been in place for decades in
many American medical schools. But just because that’s the way it’s always
been that way doesn’t mean it’s the way it should be, say members of the New
Curriculum Committee at George Washington University School of Medicine
and Health Sciences (SMHS) .
The group, an ad hoc committee of the school’s Curriculum Oversight
Group, is taking a close look at the medical education curriculum at SMHS,
as well as the curriculum at other medical schools. Based on the committee’s
feedback and recommendations, a new curriculum will be developed and is on
track to be implemented in fall 2014.
“Educating our students to serve as clinicians, researchers, and health policy
leaders is a sacred trust,” says Alex Stagnaro-Green, M.D., senior associate
dean for Education at SMHS and chair of the committee. “The process we are
undertaking is both exciting and daunting.”
The New Curriculum Committee, which has held weekly meetings since
February 2011, comprises medical students, department chairs, residency
directors, course and clerkship directors, and others. Ensuring accurate representation was a top priority when forming the group, says Stagnaro-Green.

“We want to make certain that it’s
a school-wide effort that people feel
excited about and vested in because
they were active participants in its
creation,” he says.
According to Thomas “Bruce”
Shaver, a third-year medical student at
SMHS who serves on the committee,
the approach is working. “The openness and inclusiveness of the process
has strengthened my belief that SMHS
really is a special place, and I am very
excited about the changes that are
forthcoming,” he says.
One of the committee’s first tasks
was to identify the guiding principles
that would provide a framework
for the process. They decided on
concepts that include professional
growth, taking responsibility, and early
clinical exposure. In all, the eight principles form the acronym PATIENTS.
“One of the hallmarks of GW is that
we train great clinicians,” says Stagnaro-Green. “The acronym PATIENTS
is emblematic of our commitment to
developing a curriculum that puts the
patient first.”
But the committee is not afraid to
look to other schools for curricular
inspiration. They have visited universities both near and far, including The
Johns Hopkins University School of
Medicine, The New York University
School of Medicine, and the Paul L.
Foster School of Medicine (PLFSOM)
in El Paso. Stagnaro-Green calls PLFSOM a “fascinating” model that uses
a symptom-based, not the traditional
systems-based, integrated curriculum.
Rather than mimicking any of the
other models, the new curriculum will
likely feature elements of many. The
ultimate goal, says Stagnaro-Green, is
to create the best possible curriculum
for the next generation of GW-trained
physicians. “The new curriculum process will serve to maintain GW as a
national leader in medical education,”
he says. n
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Travis O’Brien, Ph.D., director of the Pharmacogenomics program
and associate research professor of Pharmacology and Physiology
THOMAS KOHOUT

Custom Tailoring
GW’s Pharmacogenomics Program Explores
Fashioning Individualized Drug Therapies
By Steve Goldstein

I

t wasn’t long ago when the idea of tailoring drug
therapy based on a patient’s genetic makeup, or
distinguishing which drug might be most effective in
battling a person’s cancer would be relegated to the
pages of a science fiction novel. But today, it’s called
science. Real science. Pharmacogenomics (PGx) to be
exact. The marriage of pharmacology and genetics
is a union that spawns research aimed at personalizing drug
therapies and being able to predict drug responses based on a
patient’s genetic makeup.
In addition to reducing life-threatening adverse reactions
to drugs, genetic testing itself may also be predictive of treatment failure or success. “All medications will be designer
drugs someday,” said Travis O’Brien, Ph.D., director of the
Pharmacogenomics program and associate research professor
of Pharmacology and Physiology in GW’s School of Medicine
and Health Sciences (SMHS). “PGx will be another tool in
the armamentarium in battling disease.”
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In 2005, in conjunction with Shenandoah University’s
Bernard J. Dunn School of Pharmacy, SMHS began offering the nation’s first bachelor’s degree in PGx. Courses are
primarily held at the GW campus in Ashburn, Va., and can
lead to either a bachelor’s degree in Health Science (B.S.H.S.)
in Pharmacogenomics or a B.S.H.S./Doctor of Pharmacy
(Pharm.D.) dual degree.
O’Brien said the goal of the program is to educate a new
generation of Health Sciences graduates “who are acutely
aware of the interface between human genetic variability
and drug action, as well as the role that genomics can play in
identifying biomarkers for disease and targets for therapy.”
Students in the program participate in the groundbreaking
research led by O’Brien, who received his doctorate in Toxicology from the University of Cincinnati College of Medicine.
One study looks at the drug Warfarin, an oral anticoagulant
typically given to patients at risk of stroke, deep vein thrombosis, or other types of cardiovascular disease. Though Warfarin

is prescribed millions of times each year, the drug is difficult
to manage. It inhibits a key gene that promotes clotting, and
it’s also deactivated by a liver enzyme. In patients who inherit
a genetic variation in that enzyme that slows their metabolisms, Warfarin gets broken down at a slower rate. This
variation might cause the drug to stay in the body longer, and
increase the chances of negative side effects like bleeding.
O’Brien’s research team, which includes April Barbour,
M.D., M.P.H., associate professor of Medicine at SMHS,
and Arthur Harralson, Pharm.D., of Shenandoah University,
focuses on drug metabolism in African Americans. While
there are known genes that affect the metabolism of the anticoagulant Warfarin in Caucasians, those that affect metabolism in minorities are not well-defined, the team explained.
“Warfarin has a narrow therapeutic window and its
metabolism is affected by many factors, including genetic
variation,” said Barbour. “Knowing genetic information
helps physicians initially choose the proper dose of Warfarin
and then manage patients over time. This has the potential to
reduce morbidity and mortality.”
“There’s probably no other drug in the world that has
genetic information that’s so well-linked to the dose someone
is receiving,” O’Brien added.
The study is still in the recruitment phase, which O’Brien
expects to complete by year’s end. DNA will be collected
from study subjects and then isolated and analyzed at the
PGx program lab in Ashburn, where the samples will be
subjected to DNA sequencing. O’Brien said such research can
reduce health care costs “and work as a preventative measure
to decrease the incidence of adverse drug reactions associated
with Warfarin.”
A second area of research is in Reproductive Endocrinology. Along with Paul Gindoff, M.D., professor of Obstetrics
and Gynecology at SMHS, and director of GW’s Fertility
and In Vetro Fertilization (IVF) Center, O’Brien and other
researchers are examining genetic biomarkers in different
populations to find a model that can predict how women will
respond to ovarian stimulation therapy. Virtually all women
undergoing fertility treatments receive such therapy; nearly
10 percent of them suffer from moderate to severe Ovarian Hyper Stimulation Syndrome (OHSS), a condition that
can lead to complications such as ovarian torsion, ovarian
rupture, and thrombophlebitis.
“This model will help patients decide whether they want
to undergo the therapy and help physicians decide how to
treat patients who respond poorly to it,” said O’Brien. A
second phase of the research, he said, is a case-control study
that examines blood samples from patients who have had
OHSS and compares them to those who responded normally.
If the latter is found to have a different genotype than those
who experienced toxicity, “you could create a simple genetic
test that will let a woman know whether she’s at risk of overstimulating,” O’Brien noted.

Gindoff called the research a potential “grand slam.”
In the future, he said, predicting who is at risk to develop
OHSS “will save a lot of people angst and medical treatment
because we can be sure to treat them more appropriately.” He
added that it might also indirectly increase the success rate of
IVF because the procedure could be performed safely in more
cases. For example, if someone is overstimulated, many times
you can’t finish the cycle, so if you can do this more safely
then you can finish the treatment and help more people who
might not otherwise be helped.”
O’Brien is also excited by the prospect of targeting cancer
with genetically tailored medications. Since cancers are typically diagnosed with a biopsy, physicians might be able to use
those tissue samples to study the DNA of the cells. This technique could lead to selecting a drug and dosage that is most
suitable for combating each patient’s specific form of cancer.

“All medications will be designer drugs
someday. Pharmacogenomics will be another
tool in the armamentarium in battling disease.”
Travis O’Brien, Ph.D.
“One person’s liver cancer is not the same as another’s,”
he said. “With better understanding of these variances, we
will be able to treat cancers differently and that’s a major
area where genetics research will have a big impact.”
O’Brien hopes that the PGx program will help to shape
how future health care professionals think about and treat
their patients. Joseph Bocchino, Ed.D., M.B.A., interim
senior associate dean for Health Sciences, said that pharmacogenomics “specifically moves us closer to being able to treat
a patient as an individual human being, as opposed to taking
the results from a clinical trial with 5,000 subjects and treating an entire universe of people.”
Currently, the innovative program has 16 students. But
Bocchino suspects it will expand. “If I was talking to a high
school graduate, I would say that this program offers multiple
pathways to science, the retail pharmacy business and industry, and it offers a seamless route to a Pharm.D. degree,” he
said.
For years, physicians have spoken about providing personalized medicine, but the reality was mainly restricted to diet,
age, lifestyle, and health status. O’Brien believes that Pharmacogenomics has the potential to truly realize the promise
of the field. “It’s the ability to take genetic information and
apply it to patient care,” he said, “which ultimately will lead
to better health care overall.”
For more information about Pharmacogenomics research
and GW’s Pharmacogenomics degree program, visit
gwumc.edu/pharma. n
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RETIRED FACULTY MEMBERS DRAW
ON DECADES OF EXPERIENCE TO
TEACH THE PRINCIPLES OF PRACTICE

The Art
of Healing

S

By Thomas Kohout

esum Moosavi, a third-year medical student in the George Washington University School of Medicine

and Health Sciences (SMHS), enters the dimly
lit hospital room. He introduces himself and
briefly explains what he is there to do.
The patient is a heavy-set, African American male in
his mid-40s complaining of dizziness, slight abdominal discomfort, and dark urine.
Moosavi begins the examination by taking the
patient’s medical history, as Robert Wilkinson, M.D.,
M.A.C.P., professor emeritus of Clinical Medicine,
a Board Certified Internist with nearly 50 years
of experience under his belt, sits quietly observing
Moosavi’s interaction, his forward-leaning posture,
eye contact, and his relaxed but methodical line of
questions. Wilkinson takes notes as the student asks a
series of questions aimed at developing a differential
diagnosis. When Moosavi indicates he has completed
the history, Wilkinson asks a few additional questions
for clarification before the student moves on.
Wilkinson makes notes on a 40-point checklist as
Moosavi continues on to the physical exam, checking
the patient’s pulse, inspecting his eyes for jaundice and
observing their pupillary reflex, and then continues
through the steps to an efficient physical exam.
Gently tapping on the upper body, Moosavi listens
carefully to the quality of the sound his fingers make.
The difference in tone — resonant or hyper-resonant,
flat or dull — tells a physician a great deal about
the underlying structure. Dullness could indicate an
underlying collection of fluid or possibly a mass.
Moosavi next guides firm but careful fingers
over the patient’s abdomen, probing the stomach
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and tracing the outline of the liver to get a sense of
his condition. At the end, Moosavi glances over at
Wilkinson as if to ask, “Well, how did I do? Did I
leave out anything?”
The two chat briefly with the patient, each thanking him for his time, and then retire to debrief in an
empty lounge, where the real learning begins.
TEACHING THE HEALING TOUCH
For nearly 20 years, a small band of retired SMHS
clinicians like Wilkinson have been working to hold
the line on hands-on care, ensuring that the doctors
trained at GW know as much about the art of healing
as they do about the science of medicine.
Since the early 1990s, every third-year medical
student has taken Observed History and Physical
Examination, a two-hour assessment of what Sir
William Osler, the Canadian physician credited with
first leading medical students out of the lecture hall
and into the exam rooms, once called the “principles
of practice.”
The course was developed by Stanley J. Talpers,
M.D., a long-time clinician with the George Washington Medical Faculty Associates and former SMHS
faculty member. After teaching in the Practice of
Medicine (POM) program for about 15 years, former
chair of the Department of Medicine George Rios,
M.D., urged Talpers to launch a different type of

program. Together they developed a course to offer
third-year medical students an individualized critique
of their examination and patient history skills.
Today, Talpers and eight fellow physicians —
mostly former internists and all with some current or
former GW affiliation — offer up decades of bedside
exam experience during extensive evaluation sessions.
THE DEBRIEFING
Following Moosavi’s examination, he and Wilkinson
sit down to discuss how things went. After reviewing
the proper use of the ophthalmoscope and the appearance of the fundus, Wilkinson suggests Moosavi and a
classmate visit the exam rooms at the Clinical Learning and Simulation Skills Center — GW’s hands-on
clinical educational environment. Then they discuss
the patient, whom Wilkinson had handpicked earlier
that day, asking the patient if he would be willing
to participate in the teaching exercise and determining whether his case would be suitable for Moosavi’s
history and examination.
“I thought Moosavi did quite well,” says Wilkinson. “When the patient didn’t want to go into details
about his mental health history, the student didn’t
press him or get confrontational. Ultimately he developed such a good rapport that the patient disclosed his
mental health status anyway.”
TEACHING THE SKILLS
Each year, some 180 third-year medical students take
this rite of passage as they move through the Department of Medicine during their clinical rotations. They
have already covered the skills required to take a
patient history and give a physical exam during their
first two years of POM. But often by the time students
advance to their rotations something has gotten lost.
What Talpers calls the “skill of touch” is the point
where medicine leaves the scientific arena and moves
into the world of art. “That art is fading,” he says.
Those skills have diminished in value as access to
high-tech testing equipment becomes more commonplace. When students begin their rotations, they’re
often left dazzled by that technology, and it’s hard for
them to recall those basic skills they’ve learned as well
as their value.
“The generation I came out of had little technology,” recalls Talpers. “When I was a young doctor
we relied heavily on physical diagnosis; that was an
important part of a careful examination.”
Ironically, through the SMHS POM program
and the Observed History and Physical Examination
course, Talpers believes that today GW might actually be doing a better job of teaching these skills than

ever before. When he was a young medical student,
Talpers’ examination training came mostly through
observing residents and doctors performing exams.
“We’re teaching that now over the first two years,”
he says. “We teach it very well and make it stick.
That’s what this course is about — making those skills
stick.”
An important part of this program, says Wilkinson, is that it’s not graded. “I explain that this is
purely for their benefit. The students genuinely like
the program, not just because
they aren’t graded, but also
because they are getting
feedback from us. If they do
something wrong in the physical examination we say, ‘wait,
why don’t you try doing that
this way.’ ”
Following the exam, physicians and students sit down to
go over the procedure. They
discuss how things went and
explore ways to move beyond
any tricky parts. Students,
says Talpers, listen carefully
when they’re critiqued. “We
are giving them something invaluable, that one-on-one
time and immediate feedback. That’s precious.”
Many students ask if they can do it over, say Talpers and Wilkinson, and some have suggested each
student get a chance to take the course at the start of
third-year rotations and again at the end. Unfortunately, there aren’t enough physicians to critique all of
the students twice. In fact, time is a large part of why
the course is led by retired or semi-retired physicians.
Between the exam and the critique, physicians spend
at least two hours with each student.

“We are giving them
something invaluable,
that one-on-one time
and immediate feedback.
That’s precious.”
Stanley J. Talpers, M.D.

LASTING INFLUENCE
Wilkinson and Talpers agree that the goal of this
program is not to move clinical practice back to a
19th century mindset. Modern diagnostics are crucial
in the treatment of serious illnesses. But, they add,
a physician armed with good examination skills can
pinpoint most illnesses just as effectively, possibly
faster, and certainly more efficiently than blindly
ordering a battery of tests.
“If we could influence our students in these two
hours, instilling these good habits and developing the
skills that have become part of doctoring for a very
long time,” says Talpers, “they could do a better job
diagnosing their patients and getting the right answer
the first time.” n
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By Steve Goldstein | Photography Courtesy of Glenn Geelhoed, M.D.

Building
Sudan
on the Run

T

hey were running, running. In the
morning light, the only sounds were
heavy breathing and the rhythmic
flap-flap-flap of worn-down sandals
as the tribesmen clicked through the
scrub atop the hard baked Sudanese
laterite. Some giggled as they followed the white
man. “Why is this crazy khawaja using up all our
energy? Why run unless someone is chasing you?”

But they kept running.

Glenn Geelhoed, M.D.
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Glenn Geelhoed, M.D., greets patients waiting outside a rural clinic.

Glenn Geelhoed, M.D. — surgeon, medical missionary,
marathoner, proselytizer of peace — has indeed been called
crazy. His latest plan — to unite the warring tribes of South
Sudan around a marathon team to compete in the London
Olympic Games this summer — was seen by some as wishfulness bordering on fantasy.
But Geelhoed, or Doc G as he’s known in the bush, has
defied doubts and exceeded expectations before. Indeed, he’s
made a career of it, spending more than 40 years leading
medical missions to the most poverty-stricken, desperately
underserved regions of the world. In addition to ministering
to the poorest of the poor, he’s trained generations of young
doctors while establishing clinics in remote locations from
Southern Sudan to the Philippines to Haiti.
Geelhoed holds the unique distinction of being the only
five-time GW alumnus, earning advanced degrees from
four of the university’s 10 schools. He came to GW’s School
of Medicine and Health Sciences in 1975, and now holds
professorships in Surgery, International Medical Education,
and Microbiology and Tropical Medicine. But his OR is the
world. He’s received the American College of Surgeons’ 2009
Volunteerism Award for International Outreach, the 2008
Safari Club’s International Humanitarian Service Award,
and, in 2005, was inducted into the Medical Mission Hall of
Fame.
But the latest mission? Let’s just say it’s made Geelhoed
acutely familiar with the old Yiddish saying, “Man makes
plans, and God laughs.” Still, progress has been made and the
dream lives on. There’s another saying Geelhoed prefers: “A
16 smhs.gwumc.edu
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journey of a thousand miles begins
with a single step.”
The former colony of Sudan
gained independence from the British
in 1956, but has known little peace
since; two civil wars have killed
millions and displaced millions
more. In 1983, the military regime
attempted to impose Islamic law,
triggering a separatist rebellion in the
south of the country, home to a third
of the population who hold Christian or animist beliefs. War raged
for more than 20 years until a peace
agreement was signed in 2005. But
the Comprehensive Peace Accord did
not quell the strife and the missions
led by Geelhoed, who first came
to South Sudan in 2005, have been
marked by conflict, including cattle
and bride raids, kidnappings, and
murders.
In January 2011, South Sudan
voted overwhelmingly for independence
and a new state was formally declared on July 9. Interethnic clashes among the Dinka people (about three million),
the Nuer people (about two million), and the Murles (about
400,000) persist, however, thanks to problems like the high
rates of infertility among Murle women that motivate their
tribe to capture Dinka brides.
Having run more than 100 marathons, with at least one
on every continent on the globe, Geelhoed can rightly be
called an addict. His lean, compact physique and the sharp
planes of his face accentuate his deep-set eyes. Given the
endorphin rush that produces a sense of well-being, Geelhoed, who recently turned 70 and who runs wherever he
travels, thought that running might serve as a path toward
peace and the restoration of health care for an impoverished
population. Perhaps sport could be a mechanism to defuse
ethnic rivalries, he mused.
As part of a ceasefire agreement he brokered among the
warring tribes in early 2010, Geelhoed pledged to deliver a
40-foot shipping container of medical equipment and a team
of professionals to outfit clinics and train medics to treat the
Murle and Dinka people and hopefully address the infertility
issue. But the ceasefire didn’t hold. “Why should I talk to you
about malaria and TB when your biggest health problem is
hostility?” a disappointed Geelhoed told the tribes. “I’m not
going to redevelop your health care until hostilities cease.”
New pledges of peace were renewed. When he returned in
January 2011 with the promised supplies, Geelhoed said they
would only be distributed if the tribes worked together. As
an additional carrot, he promised to rebuild the Lakurnyang

Missionary Hospital in Pibor in Jonglei State in the eastern
part of the country.
Meanwhile, Geelhoed continued running. Sometimes,
tribesmen joined him. Maybe this could be a natural way
to commemorate the Jan. 9 vote approving a new state, he
thought, successfully implementing a “Jonglei Freedom Run”
in Pibor. More than 400 tribesman ran some 15 kilometers
through the dusty scrub, vying for the honor of beating the
khawaja. Every African who finished received a medal in the
shape of a whistle and 10 Sudanese pounds, or about $5.
This idea has legs, Geelhoed thought. His next step was
planning a “Jonglei Independence Run,” uniting the tribes
in a ceremonial jaunt in January 2012 on the anniversary
of the vote for secession. Through a connection with famed
American marathoner Bill Rodgers, Geelhoed’s plan came
to the attention of the organizers of the Los Angeles Marathon. In return for exclusive rights to publicize the Sudanese
connection, marathon officials agreed to pay expenses for the
winning male and female runners from each tribe in the Independence Run to race in the L.A. Marathon on March 18,

Marathon t-shirts, medals, and spare running shoes, Geelhoed found that hostilities had resumed between the Nuer
and the Murle tribes, leaving scores dead. Some Dinka leaders, sensing better odds of going to the United States, wanted
to go ahead with the run anyway. No way, said Geelhoed,
in his direct, Dutch manner. “I came here for the benefit of
all,” he said. “So the race is off, no trip to LaLa Land and
maybe no Olympics.” The tribesmen suggested an alternate
plan to hold the run this July on the first anniversary of the
new state, but the rainy season would flood the racecourse.
“There will be no race until it’s an all-tribes race,” Geelhoed
declared.
For Geelhoed, who’s worked in Africa for four decades,
this is merely a bump in the road. “The most likely scenario is
I return to South Sudan in July and the tribes agree to run in
the dry season beginning in November and then the winners
train in Kenya,” he said. “Then all we have to do is create
a National Olympic Committee and prepare for the 2016
Games in Rio de Janeiro, Brazil, by training on a measured
course.”

Left, Glenn Geelhoed, M.D., treats a Murle woman just returning
from exile. Above, Murle people outside the Lakurnyand Clinic
waiting to receive treatment.

2012. Geelhoed leapt at the deal. Further discussion yielded a
promise to help train the same runners to potentially compete
as a South Sudan Olympic Marathon Team at the London
Olympics.
So, what happens? God laughs. Returning to South Sudan
last December to prepare for the run, bearing 750 L.A.

Mafi mushkila (no problem), as the tribes say.
Geelhoed is convinced that sport can bridge ethnic
divides, pointing to the unifying effect of rugby in South
Africa and basketball in the Middle East. For him, this is one
more mission, and a necessary step on the journey to ending
hostilities and restoring health care. “I go out there and see
what’s possible,” he said. “Some of the missionaries said they
can’t believe I’ve gotten this far. You can go a long way when
you’re not concerned with who gets the credit, and my goal is
not to leave fingerprints. This is up to them.” n
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When Class
Gets Personal
Students examine their genomes in innovative course

N

ick Hazen’s computer screen stared back at
him like a reflection in a funhouse mirror.
Laid out in colorful charts, and enhanced
through explanatory slides and expert
quotations, it’s a visage of someone both
familiar and unrecognizable.

According to the graphics, Hazen was a
30-year-old blue-eyed man of European descent who could digest
lactose. That much he already knew. But he was also described as
a person with a low risk for heart disease and an elevated risk for
Alzheimer’s disease. That bit — and much more — was news.
Hazen, a second-year medical student at the George Washington University School of Medicine and Health Sciences
(SMHS), had sent away a swab of his saliva several weeks
earlier to 23andMe, a company that analyzes DNA for disease
risk, drug resistance, and ancestry. When the results popped
into his inbox, his gene-deep journey to self-discovery began.
But unlike most of the company’s customers, Hazen’s
pursuit wasn’t motivated by fear, marriage, or a genetic
counselor’s nudging. Like several dozen other GW medical
students, Hazen was preparing for class.

ACADEMIC INNOVATION
Tim McCaffrey, Ph.D., professor of Medicine and director
of the Division of Genomic Medicine at SMHS, calls pushing
the curricular envelope “academic innovation.” He knows his
course, “GNMX201: Personalized Genomics: An Exploration
into the Heritable Elements of Disease,” is unlike any other.
“I’ve never taught a course like this before; and as a
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matter of fact, there are only two or three medical schools
around the country that are teaching similar courses,” he tells
his students during the first lecture. “What’s different about
it is that it’s interactive — you can learn things about yourself
that you really couldn’t in other types of courses.”
That’s for sure. The course, which was first offered in
the summer of 2011, gives each student the chance to have
his or her genetic makeup, or genome, scanned by 23andMe
for more than one million variations in DNA called Single
Nucleotide Polymorphisms (SNPs). The company compares
the individual’s outcomes with a database of SNPs to predict
the relative likelihood of developing more than 100 diseases.
Their results can be viewed by logging into a personalized
page on the 23andMe website.
McCaffrey’s students can opt to work with an anonymous set of DNA. However, most — if not all — use their
own. The program not only reveals personal risk for disease,
it also teaches the students about each condition through
slides, video explanations, and a physician’s perspective.
The website is satisfying even “for those of us who are really
super wonky,” says McCaffrey, because it describes precisely
which gene is affected by the variation, where it is located
in the genome, and how it’s connected with disease. For the
skeptical type, 23andMe links to the studies that support
its conclusions and updates users’ results as new research is
released. “It’s a hypochondriac’s dream,” McCaffrey adds.
It’s also a professor’s dream: the ability to personalize
lessons that would otherwise be hypothetical. Using the
students’ experiences with the program as the backdrop
makes class discussions on DNA sequencing, guest lectures

McCaffrey. “We know now that
a familial risk and genetic inheritance are not identical concepts.”
GNMX201 also stresses the
important difference between
disease risk and diagnosis. McCaffrey, for example, is more than
two times as likely as the average
person to develop Crohn’s disease,
according to his 23andMe results.
But with a risk of 1.2 percent, his
chances are still small.
Whether or not an elevated risk
progresses into an actual diagnosis
depends, to varying degrees, on
both nature and nurture. Some
diseases, namely Alzheimer’s and
Parkinson’s, however, are believed
to be almost exclusively nature —
so much so that a consumer’s risk
Tim McCaffrey, Ph.D., discusses the implications of personalized genomics.
for them is guarded by an extra
“lock” on 23andMe.
about the statistical methods behind risk assessment, and
“[Unlocking the information] is a decision you should
readings regarding the ethical, legal, and social issues
really think about because as far as we know, there’s almost
surrounding genetic analysis all come to life. McCaffrey
nothing you can do about [those diseases],” says McCaffrey.
records each lecture so that his students — some of whom
“I tell the students ‘don’t do it, don’t look. You have nothing
travel internationally pursuing research projects through the
to gain by it. If it’s going to affect you at 50 or 60 years old,
Gill Fellowship Program, which awards medical students
why would you want to worry about it now when it might
a summer stipend for conducting research with faculty
well be cured by then?”
members — can watch them from around the world or refer
to them from their homes.
ACTIONABLE INFORMATION
As the syllabus promises, “By exploring their own genome
Fortunately, dead-end information is rare in personaland heritable disease risk … the student will become familiar
ized genomics. Most of what’s gained is “actionable,”
with the terminology, the methods, the proper interpretation,
says McCaffrey, and can be used to influence behavior
as well as the strengths and weaknesses of this approach.
change, initiate doctor-patient discussions, or inform
Because patients are now obtaining this information on their
medication dosages.
own … this is an eminently practical course that will foster
Personalized genomics is, by its very definition, personal.
an informed and responsive physician.”
But for students who take GNMX201, its real value is not
what they learn about themselves, but what they learn about
WE ARE ALL SUSPICIOUS
patient care.
McCaffrey presumes that most students are drawn to his
“People are doing this — and they’re doing it without
class, an elective, out of curiosity. “Whether we like it or
their physicians,” says McCaffrey. “Then, they go to their
not, we all are suspicious of what we are at risk for,” he says.
physician, and the physician doesn’t have a clue what they’re
“Tapping into that curiosity helps us engage students in learntalking about because they were trained 30 years ago. They
ing about the genetic contribution to disease.”
just don’t know how to deal with it.”
For Hazen, whose family has a history of heart attacks
But with the help of courses like McCaffrey’s, the next
and strokes, those suspicions were related to his heart. But
generation
of physicians will know how to deal with it. After
23andMe had different hunches, illustrating a key concept
all, they will have gone through it themselves.
of the course: there’s a difference between family history
“This course is not required, and it won’t be on the
and heredity.
boards,” says Hazen. “But it’s a perfect example of how GW
“Up until now, family history has pretty much been
does a good job preparing us for life after medical school: It’s
taken as indicative of there being some heritable predispooffered for the purpose of making us better physicians.” n
sition involved in a particular disease or condition,” says
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A Legacy of
Discovery
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ome are born scientists, some have science thrust upon them and, in the
case of Michael I. Bukrinsky, M.D., Ph.D., some have a family history
that conveys a certain inevitability to their life’s work. Fortunately for the
George Washington University School of Medicine and Health Sciences
(SMHS), where Bukrinsky serves as professor and interim chair of the

Department of Microbiology, Immunology, and Tropical Medicine, his family was also
instrumental in ensuring that his groundbreaking work in HIV biology and drug design was
done in the United States and not in his native Russia.
With a research focus on HIV biology and inflammatory
diseases, Bukrinsky and his team have been studying cardiovascular disease in HIV-infected patients. In addition to his
leadership role in the department, Bukrinsky is one of the
senior researchers leading GW’s Washington, D.C. Developmental Center for AIDS Research (D.C. D-CFAR), which is
charged with providing scientific leadership and institutional
infrastructure to promote HIV/AIDS research and to develop
the next generation of investigators.
Yet all of this might never have been.
Science is literally in Bukrinsky’s DNA. His father, Ilya
Shapiro, was a prominent biologist and his mother a virologist. When they weren’t working at their labs, his parents
poured over difficult-to-obtain scientific journals, which were
in short supply in the Cold War-era Communist Soviet Union.
“I saw them reading all the time and they seemed happy
and excited,” recalled Bukrinsky, “so by age 10 or 11, I had
decided that I was going to be a scientist, too.” His parents
sent him to Moscow School No. 2, the top mathematics
school in the city, whose director would later be persecuted
by the Soviet authorities for allowing too much free speech.
Later, Bukrinsky would attend Moscow Medical School
and earn his Ph.D. at the prestigious Institute of Molecular
Biology.
Meanwhile, in 1978, Shapiro defected to the West to
escape the Soviet Union’s restrictive working conditions for
scientists. With his father branded a traitor, young Michael
took his mother’s maiden name — Bukrinsky. (Augmenting his scientific pedigree, Bukrinsky’s mother later married
Viktor Zhdanov, a famous Russian virologist and Deputy
Minister of Health in the USSR, who led the effort to eradicate the smallpox virus.) By the mid-1980s, Bukrinsky began
to relate to his father’s frustration. “I rose to ‘interim junior
researcher,’ ” he said with a laugh. “It was a joke; I had no
real position.” The final straw came when Soviet authorities
rejected an invitation for Bukrinsky to visit Cuba to address
the nation’s growing HIV problem.

In 1989, the last year Jewish people were allowed to
emigrate from the Soviet Union, Bukrinsky received an official invitation to leave, thanks to his father’s friend in Israel.
Ultimately, Bukrinsky went to the United States; his mother
would follow three years later, after the dissolution of the
USSR. “I left because I wasn’t allowed to move to any position where I could do something in research,” he explained.
Shapiro was also instrumental in matching his son with
leading HIV researcher Mario Stevenson, Ph.D., at the University of Nebraska in Omaha. It was a good fit: Bukrinsky
stayed for three years and the lab published numerous papers
in top journals. “This was the time my future interests were
formed,” said Bukrinsky. Then fate took another turn when he
met Anthony Cerami, Ph.D., who was head of a research institute at North Shore University Hospital on Long Island, N.Y.
“We had decided to expand the scope of our research to
include HIV and, after calling people in the field, we identified a young investigator named Michael Bukrinsky,” said
Cerami, a distinguished researcher who pioneered the hemoglobin A1c test used by diabetics worldwide and founded the
Warren Institute, a not-for-profit that conducts biomedical
research. “I worked with Michael on several aspects of HIV
and enjoyed every moment. He is without a doubt one of the
leaders in the field today,” said Cerami.
The two became close friends and when Bukrinsky
expressed a desire to find a new position, Cerami endorsed
GW, which was actively expanding its Department of
Microbiology, Immunology, and Tropical Medicine. In 2001,
Bukrinsky arrived on campus and, in a short time, according
to his peers, managed to rise to the top of a highly competitive HIV/AIDS field. He’s also become an admired mentor,
training doctoral students who have gone on to some of the
best laboratories in the world. One of them, Sergey Iordanskiy, Ph.D., was a postdoc from 2001 through 2007 and now
continues to collaborate with Bukrinsky as a member of the
research faculty at GW. “Michael is a fantastic mentor and
scientific adviser who allows us to work almost independently.
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He always considers the opinions of young scientists and
guides them in the right direction when problems arise,” said
Iordanskiy.
Bukrinsky’s lab has focused on, among other projects,
analyzing cholesterol metabolism in HIV-infected cells to
understand why people with HIV are at increased risk of arteriosclerosis. As anti-retroviral drug regimens have allowed
HIV patients to live longer, a clinical problem has arisen
because they are developing arteriosclerosis at an earlier age
than the general population. At first, Bukrinsky said, experts
thought that the increased risk was related to the drugs, but
that theory was proved false. “In fact, tests showed that when
taken off drugs, the risk actually went up — not down,” said
Bukrinsky. “That’s when we came in with our project.”
MICHAEL LEONG

Bukrinsky’s team discovered that the HIV virus has a
specific effect on cholesterol metabolism by inhibiting a critical cholesterol transporting mechanism. Specifically, the HIV
virus suppresses cholesterol efflux, which is critical for maturation of the high-density lipoprotein (HDL) particles, the key
atheroprotective factor in blood. The HDL particles perform
two functions: anti-inflammation and prevention of plaque
formation in the arteries. But HIV patients have low levels of
HDL, explains Bukrinsky.
Once the role of HDL in arteriosclerosis was discovered, pharmaceutical companies went to work on drugs that
stimulate the transportation of cholesterol. Bukrinsky’s team
capitalized on these developments, finding that the same
drugs also inhibit viral replication. “This suggests that these
drugs will be of dual benefit to the patients — they will not
only fight arteriosclerosis but they’ll also inhibit replication of
the HIV virus. This is really very exciting,” Bukrinsky said.
Alan Remaley, M.D., Ph.D., a well-known HIV expert
at the National Institutes of Health, said Bukrinsky’s work
on the role of cholesterol and lipid metabolism in AIDS
“holds great promise” regarding the effect of some HIV
drugs on lipid and lipoprotein metabolism. He also praised
22 smhs.gwumc.edu
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Bukrinsky’s finding that the replication of HIV itself is in-part
dependent upon cholesterol metabolism. The viral effect on
cholesterol metabolism and trafficking has been observed in
other viruses, suggesting that it can be used as a target for
therapeutic approaches against HIV as well as other viruses.
“This creates the opportunity to perhaps control the replication of HIV,” said Remaley. As a result of these observations,
Bukrinsky is cited as an author on more than 10 U.S. patents.
With 2011 marking the 30th anniversary of the battle
against HIV/AIDS, Bukrinsky’s work comes amid other
breakthroughs such as the discovery that an HIV-infected
individual can reduce the risk of sexual transmission by
beginning anti-retroviral drug treatment sooner. Other
successful interventions have helped prevent HIV-infected
mothers from transmitting the virus to their children during
birth. All are steps toward what the Obama administration
calls an “AIDS-free generation.”
“A vaccine will be the ultimate solution for the epidemic,
but I don’t think this would solve all the problems,” said
Bukrinsky. “To me, the real solution would be to cure the
disease, to make people who have it free of the virus.” To this
end, Bukrinsky’s research has focused on the use of therapeutic, not preventative, vaccinations. His lab is working to
better understand latently infected cells, which remain in the
body throughout a patient’s life and may become active when
drug therapy is stopped.
In addition to his administrative responsibilities as acting
chair, there is Bukrinsky’s work with the D.C. D-CFAR,
where he directs two of the five “cores” that provide support
for HIV-related research in Washington. He is in charge of
the developmental and basic science cores; the other three
include administrative, clinical and behavioral science, and
prevention and biostatistics. He has noted a shortage of HIV/
AIDS researchers doing basic science work and said, “this
is an area we need to develop in order to support the other
research studies [and] the only way to accomplish that is to
attract new people, especially young investigators.”
For Bukrinsky, that “next generation” begins at home. His
youngest daughter is in high school, his oldest daughter is a
lawyer in Virginia, and his son just started medical school in
Grenada. Not surprisingly, his wife, Tatiana Pushkarsky, is a
research scientist in his department at SMHS.
Thinking back to those nights watching his parents read
scientific journals at home, Bukrinsky sees the same sense
of excitement and discovery in the young researchers he’s
mentored. He doesn’t regret his decision to “escape,” as he
has put it. “If I had stayed in Russia, I’d still be a scientist, but
I wouldn’t be able to do what I’ve achieved here,” he said. “I
know I did the right thing.”
For more information about Michael Bukrinsky, M.D.,
Ph.D., visit www.gwumc.edu/bukrinsky. n
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Matter Over Mind
RESEARCHERS IDENTIFY GENE INVOLVED
IN WHITE MATTER DEVELOPMENT

A

By Anna Miller

t first, Li-Jin Chew, Ph.D., research assistant
professor of Pediatrics at the George Washington University School of Medicine and Health
Sciences (SMHS), and Vittorio Gallo, Ph.D.,
professor of Pediatrics and of Pharmacology
and Physiology at SMHS, were in the dark.
Their eight-year venture to better understand how the brain makes and repairs myelin — a coating
that insulates the axons of neurons and that, as a whole, is
referred to as white matter — began slowly with little funding
and few clues.
“At the beginning, there were many reasons we were
crawling,” admits Chew, who is an investigator at the Center
for Neuroscience Research at the Children’s Research Institute
at Children’s National Medical Center (Children’s National),
where Gallo is director and Wolf-Pack Chair in Neuroscience.
A break in the clouds came during an early screen, when
the lab found that a gene called Sox17 was being regulated
during myelination, or the formation of white matter.
Although pinpointing this gene was no minor accomplishment
(the finding was published in The Journal of Neuroscience in

2006), it left questions unanswered. What function did Sox17
have, and how does it work?
The researchers knew the answer wouldn’t come easy. The
gene, which resides in many types of cells and is expressed
only weakly and temporarily in developing white matter, is
inherently difficult to study.
But recently, the Chew-Gallo team reached a major turning point in their research. In a study published online in
the September 2011 edition of The Journal of Neuroscience,
they identified Sox17 as a gene that helps direct immature
brain cells (called oligodendrocyte progenitor cells) to mature
and generate myelin through its regulation of the Wnt/betacatenin signaling pathway, a major pathway implicated in
white matter development and in some forms of brain cancer.
A glitch in these signals can result in mental retardation,
developmental disabilities, and diseases of adult white matter
such as multiple sclerosis.
“We were very excited because we were beginning to get
a coherent picture of the interplay between these molecular
mechanisms and the pathways that regulate oligodendrocyte
development,” says Gallo. “The more we understand molecular mechanisms, the more we open our possibilities to target
them with specific drugs.”
While the development of oligodendrocytes is studied
widely, Chew and Gallo’s team is the only group to study
Sox17’s role in this process. They are working toward renewing the NIH grant they were awarded five years ago, and are
collaborating with researchers in France on a project funded
by the National Multiple Sclerosis Society.
“We are very interested in expanding this study to understand the relevance of this gene in human cells and pathology,” says Gallo.
The success of the Chew-Gallo lab — which has trained
top researchers in white matter development, including Jiho
Sohn, Ph.D., who led the 2006 study as a GW graduate
student and is now studying myelination as a postdoctoral
fellow at the University of California, Davis, and Shibeshih
Belachew, M.D., Ph.D., an initiator of the first screen who
has since established the largest center for multiple sclerosis research and clinical care in Belgium — is attributable
to teamwork and the robust environment for neuroscience
research at Children’s National and at GW, home of the GW
Institute for Neuroscience, they say.
“I think this study really exemplifies what we are all doing
at GW and Children’s National,” says Gallo. “We are identifying mechanisms that might be used to manage abnormalities in disease.”
For more information about the Center for Neuroscience
Research at Children’s National, visit www.childrensnational.org/research/OurResearch/centers/neuroscience/default.aspx. n
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Rep. Donna Christensen, M.D. ’70

Where Opportunities Lead
Rep. Donna Christensen, M.D. ’70, Follows the Path from St. Croix to Capitol Hill

D

onna Christensen, M.D. ’70, never intended
to go into medicine. When her father, a former
United States Attorney and Judge in the U.S.
Virgin Islands, suggested she consider a career
as a physician, the strong-willed island-girl
from St. Croix wouldn’t hear of it. Although
she says she was always interested in science
and biology, becoming a doctor was a decision that came
later. Christensen never intended to go into politics either, but
somehow a series of influential moments ultimately led her to
GW’s School of Medicine and Health Sciences (SMHS). From
there Christensen developed a successful career in family
practice, became the first female physician to serve in the
House of Representatives, and most recently, Christensen will
serve as the keynote speaker at her alma mater’s graduation
ceremony on May 20.
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By Thomas Kohout
Medicine came to Christensen in the midst of her
sophomore year at Indiana’s St. Mary’s College, where she
was studying biology. “I picked up some pamphlets about
the need for African American doctors for a friend of mine,”
admits Christensen. Fortunately, she decided to read them
first, before sending them along. “After that I knew I wanted
to go into medicine. I was probably heading that way all
along, but I didn’t want to my father to think that he had
been right.”
Her introduction to SMHS came a short time later, when
her father was a patient at GW Hospital. While her father was
there for eye surgery, Christensen was busy grilling his doctor
about GW’s medical program. Based on the doctor’s candor
and his recommendation, Christensen chose GW.
“I was scared to death when I came,” she says, adding
“but GW had a very different atmosphere. All of the faculty

told us, ‘You’ve made it. We expect you all to graduate, and
our doors are always open if you need any help.’ That made
all the difference.”
Washington, D.C., in the late 1960s was a good fit as well.
Vibrant and enticing, Vietnam war protestors and civil rights
marchers filled the city’s streets. Christensen and a cadre of
classmates spent their free time studying or just unwinding
at the P Street Beach near her Dupont Circle apartment, and
often found themselves at the center of everything.
She was a second-year student in 1968 when Martin
Luther King was assassinated. When the news broke, some of
her classmates thought that Christensen should leave the city
for her own safety. “We were a close-knit group and looked
out for each other. They were worried about me; afraid the
city might not be safe.
“I said, ‘No, it’s safe,’ ’’ recalls Christensen, but she ended
up spending the weekend alone, watching from the rooftop of
her apartment building as National Guard troops patrolled
the streets below and the city burned.

Christensen instead volunteered in the medical van during the
two-week campaign. She cared for the demonstrators who
came from all over the country, most of whom came from the
rural South, and the experience had a lasting effect.
“I was just finishing my second year at the time,” she
explains. “It was raining and muddy, and very difficult for
everyone. That experience is why I’m serving in Congress
today. It wasn’t a direct connection, but as I look back on it, I
think it set a direction for me.”
Over more than two decades as a family practitioner,
Christensen served in clinics and hospitals throughout St.
Croix, eventually became acting Commissioner of Health.
From there her political life began. In 1996, after a contentious campaign against Victor Frazer, Christensen won the
first of seven consecutive elections to represent the U.S. Virgin
Islands, a tiny Caribbean territory just east of Puerto Rico.
Despite her status as a non-voting member (territories are
not permitted to vote on legislation), Christensen has found
an avenue to represent her constituents: committee work.
Currently she serves on the influential House Committee on Energy and Commerce, which has a hand in
just about every issue that comes before Congress.
When she first arrived on Capitol Hill, Christensen
found willing mentors in Maxine Waters (D-Calif.)
and Louis Stokes (D–Ohio), who started the Congressional Black Caucus’ Health Brain Trust.
When Stokes retired, Christensen was tapped to
fill his place as chair of the Health Brain Trust. That
opportunity provided Christensen with a platform to
address health issues. It also led to a seat on the health
subcommittee and a major role in health care reform
legislation. Christensen and her staff began crafting
benchmarks for the legislation, forming a coalition
with the Hispanic and Asian caucuses to identify some
“non-negotiable” items — such as data collection
by race, ethnicity, and other socio-economic factors
— that the groups felt were an essential part of any
Donna Christensen, M.D. ’70, (at left facing the camera) relaxing with
classmates on the P Street Beach.
health care reform law.
The result is a law Christensen believes is a landmark piece of legislation as significant as anything
Congress has crafted in generations.
Just a month later, events in Washington would prove
In May, when Christensen addresses the graduating
even more pivotal for Christensen. The District was the site
medical students, she will encourage them to celebrate their
of the Poor People’s Campaign. Billed as the second phase of
King’s civil rights campaign, the event aimed to promote an
accomplishments and embrace unique opportunities that
anti-poverty agenda that included housing, health care, and
arise. As in Christensen’s career, it is not always predictable
economic assistance for America’s poor. In May 1968, thouwhere these opportunities will lead, however, they can serve
sands of demonstrators descended upon the National Mall
as a guide to great things.
and hastily built a shantytown known as “Resurrection City.”
For more information about how to get involved at GW
Rather than spending those days studying for her boards,
visit www.gwumc.edu/getinvolved. n
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schedule as an activist, HIV awareness campaigner, and
M.D./M.P.H. degree student.
In 2011, O’Neill, 30, was one of 34 scholars, chosen
from 2,000 applicants, to receive a scholarship from Point
Foundation, the nation’s largest scholarship-granting
organization for lesbian, gay, bisexual, and transgender
(LGBT) students of merit. Jeffrey S. Akman, M.D. ’81,
G.M.E. ’85, interim vice president for Health Affairs and
dean of SMHS, said O’Neill “is a great example of the kind
of citizen-leader that the school is proud to support.”
O’Neill graduated with degrees in Biology and Dance
from Indiana University, where he also received a fellowship
to obtain his M.B.A. in Biotechnology Enterprise. Upon
moving to the area, he co-founded the HIV Prevention

Daniel O’Neill plans to pursue a residency in
Washington, D.C. or possibly San Francisco,
where he will continue to work on HIV/AIDS
and other public health issues for the benefit

MICHAEL LEONG

of the underserved and the LGBT community.

Action Unlimited
RISING FOURTH-YEAR DANIEL O’NEILL BALANCES HIV
ACTIVISM WITH LIFE AS AN M.D./M.P.H. DEGREE STUDENT

By Steve Goldstein

H

urrying into a Dupont Circle sandwich shop
during a break in his preceptorship at a private
practice specializing in HIV patients, Daniel
O’Neill wolfed down his lunch and prepared
for his busy afternoon. A type 1 diabetic since
he was 13, the rising fourth-year student at
the George Washington University School of Medicine and
Health Sciences (SMHS) is aware that controlling his blood
sugar is the only way he can manage his extremely active
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Working Group of the Washington, D.C. LGBT Center, as
well as an organization that distributes safer-sex kits. He is a
recipient of the Unsung Hero Award from Caron Treatment
Centers, a nationally recognized non-profit provider of
alcohol and drug addiction treatment, and won a National
Health Service Corps scholarship. And in between his studies
and his work with the HIV Prevention Group, he sings with
the Gay Men’s Chorus of Washington, D.C.
O’Neill, whose father is a cardiothoracic surgeon, became
interested in medicine at a young age. Later on, he came to
understand the parallels between HIV and diabetes, both
chronic diseases that last a lifetime.
O’Neill said that his diabetes forces him to be as
regimented as possible with his busy daily schedule. It’s also
inspired him to pursue a career in outpatient care, as opposed
to a field like surgery, that’s subject to more unpredictable
demands.
He plans to pursue a residency in Washington, D.C. or
possibly San Francisco, where he will continue working
on HIV/AIDS and other public health issues. Above all, he
said, “I want to work with the underserved and the LGBT
community.” n

The Detroit-area native and graduate of Michigan State
University and Wayne State University School of Medicine
always seems to be on her toes, whether she’s treating patients
or representing her fellow residents on various committees.
Tanski is one of two co-chairs of the Residents Committee, which is responsible for bringing residents’ concerns to
the attention of the administration. And, as the residents’
representative on the Medical Executive Committee, she is
also charged with presenting these concerns to the committee of attending physicians and board members. “It’s very

As of July, Mary Tanski, M.D., will be one
of three chief residents for the Emergency
Department, in charge of everything from
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residents’ schedules to new intern orientation.

Lead Runner
RESIDENT MARY TANSKI KEEPS ONE
STEP AHEAD OF THE NEXT EMERGENCY

By Steve Goldstein

E

mergency medicine is unpredictable. Emergency
medicine at the George Washington University
Hospital is really unpredictable, as third-year resident Mary Tanski, M.D., discovered.
“You never know who or what’s going to come
through the door,” she said during a break from
the rigorous pace. “You get to treat patients from
all walks of life, with every disease process. In one bed there
might be a VIP and in the next there might be a person from a
medically underserved community. It keeps it interesting.”

interesting to hear about long-term plans at the hospital. My
participation in the meetings gives the residents a voice in
discussions about the future of GW Medicine,” she said.
As of July 1, Tanski will be one of three chief residents for
the Emergency Department. The chief residents are in charge
of everything from residents’ schedules to new intern orientation and social activities.
According to Robert Shesser, M.D., chair of the Department of Emergency Medicine in GW’s School of Medicine and
Health Sciences, Tanski “was the unanimous choice of the
faculty and her peers to be one of our chief residents. She has
become an excellent clinician who communicates well with
patients, nurses, and physicians and has demonstrated excellent administrative and problem solving skills.”
The stress of emergency medicine has never been too much
for Tanski, whose devotion to running helps keep her both
sane and slim. “If you’re working with a good team, it makes
it all manageable,” she added.
Tanski has envisioned her life as a physician since she was
in seventh grade, when she wrote a report on Ben Carson,
M.D., a fellow Michigan native and an internationally
renowned neurosurgeon. “His story was so inspiring. From
that moment, I knew I wanted to do this,” she said.
Her dedication hasn’t strayed since. Following her residency, Tanski is aiming for an administrative fellowship.
“I’m really concerned about quality improvement and patient
satisfaction,” she said. “It’s definitely my career path.”
Shesser hopes that path will also include positions of
leadership.
“I sincerely hope that she chooses academic medicine as
a career because she has the potential to make a tremendous
impact on future generations of physicians,” he said. n
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John and Katherine Pan

Well Integrated in Health
JOHN AND KATHERINE PAN TURN A LONG‑STANDING ASSOCIATION WITH GW’S
SCHOOL OF MEDICINE AND HEALTH SCIENCES INTO A MAJOR COMMITMENT

W

By Thomas Kohout

ith a connection to the GW medical community spanning more
than 30 years, it’s safe to say that John and Katherine Pan, and
their family, are deeply entwined in the George Washington
University community. John graduated from the GW School of
Medicine and Health Sciences (SMHS) in 1970, and completed
his residency in Obstetrics and Gynecology in 1974; and Katherine earned her master’s degree in Economics at GW in 1976.
Their son Eric and his wife, Krista, are also part of GW; as Eric earned his M.D. at
SMHS in 2009, and now he’s in his second year of residency at GW; and Krista is
currently pursuing a master’s degree in Education.
For many years following the completion of his residency at GW, John ran a
private practice as an OB/GYN. In 1995, he brought his practice to the GW Medical Faculty Associates and taught GW medical students the important skills needed
to be a successful gynecologist.
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However, in 1998, John took a leap
of faith and refocused his career on
Integrative Medicine, at a time when
the discipline was hardly an accepted
practice. With support from SMHS,
he launched The Center for Integrative
Medicine.
The principles of Integrative Health
are based on establishing a healing
environment where complementary
and alternative therapies partner
with conventional medical practice to
promote healing and wellness. The idea
is to develop a care plan tailored to fit
each patient’s needs, honor the personal
healing process, and treat the patient as
a whole, addressing the root cause of
disease as well as the symptoms. John’s
Center has been a part of the research
and education at SMHS since it was
established, and Integrative Medicine
has been a popular discipline available
through SMHS’s track program offered
by the Office of Student Opportunities.
The track program enables students to
move beyond the core curriculum to
emphasize one of nine available elective
paths.
“My goal is not to have a specific
department or some stand-alone entity
called Integrative Health,” explains
John. “I think the principle of the
practice is that it’s integrated through
the health education system.” The idea,
adds John, would be to incorporate
aspects of Integrative Health across
multiple disciplines in Medicine and
Health Sciences.
In April, he accepted an invitation
to become a member of the Dean’s
Council for SMHS, a key advisory and
leadership body for the school. John
is working with SMHS to create an
academic home for Integrative Health,
as it is currently based in the Center
for Integrative Medicine, which is an
independent private practice located in
Foggy Bottom.
continued on page 36

CLASS NOTES
Wartofsky Receives GW
Alumni Achievement Award
Leonard Wartofsky, M.D., M.P.H., a four-time GW alumnus, was
among those to receive the 75th Annual GW Alumni Achievement
Award during Alumni Weekend 2011. The awards are the highest form
of recognition that the University and the GW Alumni Association
bestow upon alumni each year.
A thyroid cancer expert, Wartofsky earned his B.S. from GW in
1959, a well as an M.S. in 1961, an M.D. in 1964, and an M.P.H. in
1995. He currently serves as the chair of the department of Medicine

GW Alumnus Named
President-Elect of Medical
Society of Virginia
Russell C. Libby, M.D.
’79, B.S. ’74, F.A.A.P,
began his term as
president-elect of the
Medical Society of
Virginia, a professional
association serving

at the Washington Hospital Center. In addition, he holds faculty

Virginia physicians since

appointments at GW, Georgetown University, Howard University,

1824, in fall 2011.

the University of Maryland, and the Uniformed Health Services in
Bethesda, Md.
“Throughout his long and distinguished career in medicine,

Libby is founder,
president, and medical
director of Virginia Pediatric Group, Ltd. in

Leonard has embodied the great traditions and most important

Fairfax, Va., serves as chief of the general

values of our school, as well as those of the medical profession,”

medicine section of Inova Fairfax Hospital

said Jeffrey S. Akman, M.D., ’81, G.M.E. ’85, interim vice president

for Children, and sits on the board of

for Health Affairs and dean of the GW School of Medicine and Health

directors of the American Academy of

Sciences. “He is a brilliant physician and scientist who has been at

Home Care Physicians.

the top of his field for many years, and I can think of no one who is
more deserving of this award.” n

In addition to his clinical work, Libby
helped establish the GW School of
Medicine and Health Sciences’ Adopt-A-

Global Service

Doc program, through which alumni can

Christopher L. Barley, M.D. ’93, was one of five George Washington

education with a minimum gift of $20,000

University alumni to receive the 51st Annual Alumni Outstanding
Service Award. The Alumni Outstanding Service Award is given to

support an incoming medical student’s
over four years. For information about
giving opportunities such as Adopt-A-

alumni who advance the mission of the university through dedicated

Doc, visit smhs.gwu.edu/connect/

volunteerism in support of its programs, thereby ensuring the

smhsgivingopportunities.cfm.

university’s impact on our community and future generations of
students.
Barley is a member of the School of Medicine and Health Sci-

“For more than 30 years, Russell Libby
has been a committed physician and a
dedicated member of the SMHS alumni

ences (SMHS) Dean’s Council and was instrumental in establishing

community,” said Jeffrey S. Akman,

the SMHS Young Alumni group in New York City — the school’s first

M.D. ’81, G.M.E. ’85, interim vice president

alumni group of its kind.

for Health Affairs and dean of the GW

He is a vice president of Citta, a not-for-profit organization that
builds and maintains hospitals and schools in rural areas of India,

School of Medicine and Health Sciences.
He also has been recognized as the best

Nepal, and Mexico. In this role, Barley oversees the delivery of health

pediatrician in the Washington metropolitan

care and education to underserved communities. He also serves as a

area by Families Magazine, listed as

Diplomat of the American Board of Internal Medicine.

one of best physicians by Washington

Barley’s Internal Medicine practice in Manhattan, N.Y., focuses

Consumer Checkbook, as a Top Doctor by

on travel medicine as well as the prevention and early detection of

Washingtonian Magazine, and as one of

diseases such as cancer and heart disease. n

the 100 top physicians in the Washington
metropolitan area by Northern Virginia
Magazine. n
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1950s

MEMBERS OF THE CLASS OF 1954 gathered in downtown Washington, D.C.
during Alumni Weekend on Sept. 17,
2011, for an afternoon of reminiscing
and reconnecting. In attendance were:
Solomon Barr, M.D.; Milton Boyd,
M.D.; Robert Bullock, M.D.; Martin
Davis, M.D.; Albert Modlin, M.D.; and,
Ruth Oartel, M.D.

1960s

STEPHEN H. MANDY, M.D. ’66, was
appointed to the Board of Directors for
the American Academy of Dermatology,
and will serve through 2016. He also
serves on the board of the American
Society of Dermatologic Surgery.
DONALD BERNSTEIN, M.D. ’68, recently
retired after 39 years practicing anesthesiology to become a senior scientist with

Sotera Wireless, where he is working
to develop rapid response monitoring
devices.

BRUCE E. RUBIN, M.D., G.M.E. ’77, serves on
the executive board for the Maryland
Radiologic Society and the Washington,
D.C. Metropolitan Radiologic Society.

1970s

1980s

was selected
as one of New Jersey’s best physicians
by N.J. Top Docs in January 2012.
PETER C. FREIS JR., M.D. ’70,

ROBIN J. HAMILL-RUTH, M.D. ’80, associate professor of Anesthesiology and
Critical Care Medicine, and director,
Clinical Pain Research, at the University
of Virginia Medical Center was named
president-elect of the American Board
of Pain Medicine in February 2012.
Previously she served on the Board as
Credentials Director. She will serve
as president-elect from 2012–14, and
then she will become president for the
2014–16 term.

MARC A. MUGMON, M.D. ’73, was recently
elected Governor of the Maryland
chapter of the American College of
Cardiology.
MICHAEL E. CAIN, M.D. ’75, was recently
appointed to serve as the vice president
for health sciences at the School of
Medicine and Biomedical Sciences at
the University of Buffalo. Cain has
served as the school’s dean since 2006.

RICHARD KOVAR, M.D. ’80, was named
2012 Family Physician of the Year by
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the American Academy of Family Physicians. The award honors outstanding
family physicians who provide patients
with compassionate and comprehensive
care.
MICHAEL J. VENDRELL, M.D., G.M.E. ’80,

recently founded Ikonopedia, LLC. The
company offers image-driven reporting
and an encyclopedia of breast imaging.
JERRY OSHEROFF, M.D. ’86, Clinical
Decision Support academic at the
University of Pennsylvania Health
System, recently launched an
independent consulting firm, TMIT
Consulting, LLC. The firm specializes
in synthesizing, disseminating, and
implementing best-practices for
improving health care outcomes. In
2009, Osheroff was the lead author
of the award-winning resource guide,

Improving Outcomes with Clinical
Decision Support: An Implementer’s
Guide.
JEFFREY FISCHGRUND, M.D. ’87, was
selected to serve on the Board of
Directors for TranS1 Inc., a medical
device company focused on designing,
developing, and marketing spine
products to treat degenerative
conditions. Fischgrund currently serves
as professor of Orthopaedic Surgery
at The Oakland University School
of Medicine, at William Beaumont
Hospital in Royal Oak, Mich. A board
certified orthopaedic spine surgeon
with more than 20 years of experience,
Fischgrund has served as the Editor-inChief of the Journal of the American
Academy of Orthopaedic Surgeons
since 2009.

Make an Informer
Decision.

STUART S. KAPLAN, M.D. ’88, G.M.E. ’89,

was recently elected as a Fellow of the
American College of Radiology.

1990s

STEVEN A. ROBICSEK, M.D. ’95, PH.D.,

clinical associate professor of Anesthesiology, director of Medical Student Anesthesia Electives at University of Florida
College of Medicine, is concluding a
two-year RO1 grant from the National
Institute of Neurological Disorders
and Stroke for his research “Neuronal
Biomarkers in Severe Traumatic Brain
Injury.”
MICHAEL R. YOCHELSON, M.D. ’95, was
appointed vice president of Medical
Affairs and Chief Medical Officer for
the MedStar National Rehabilitation
Network in July 2011. He also recently

s•

1.00%

Money Market Fund

1.95%

I
'

5-year CD

5.8%

GW Charitable Gift Annuity
(donor age : 75; requires minimum $10 ,000 gift)
Charitable Gift Annuities are not investments
Not immcdiatcl y available in I
I
I , ND or WI

To learn more about how a charitable gift annuity
is good for you and for the George Washington
University School of Medicine and Health
Sciences contact the office of Planned Giving
at 877-498-7590 or pg iv ing l(a'gwu.edu ,
or visit our wcb sitc:

go.gwu.edu/planned giving
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completed his M.B.A. at the University
of Maryland, R.H. Smith School of
Business. Yochelson has also been recognized among the “Top Docs” serving
Northern Virginia in 2010 and 2011.
was
recently appointed senior associate dean
for Undergraduate Medical Education
at the Miller School of Medicine at the
University of Miami.
ALEX J. MECHABER, M.D., G.M.E. ’97,

2000s

Consumers’ Research Council of
America twice, and has a special interest in the treatment of abusive parents
with mental illness.
MARK J. FAVOT, M.D. ’08, will begin his
new position as assistant clinical professor and director of Emergency Ultrasound at Sinai-Grace Hospital, Wayne
State University School of Medicine, in
July 2012.
JENNIFER S. JACKSON, M.D. ’08, will

JOHN YARBROUGH, M.D. ’04, M.B.A.,

joined the hospital medical staff at
St. Joseph’s Behavioral Health Center.
Yarbrough, received the America’s
Top Psychiatrists Award from the

complete her Emergency Medicine
residency at Yale University School of
Medicine/Yale-New Haven Medical
Center in June 2012.
FRANCES SESSLER, M.S. ’09, has been
named the National Dean for the

Remington College of Nursing in
Orlando, Fla., where she is developing a new occupational therapy assistant program and teaching an online
research methods course.
ERIC M. THOMSON, M.D. ’09, was accepted
to the Virginia Commonwealth University’s Fairfax Family Practice Sports
Medicine Fellowship.
JOSEPHINE SCHLOESSER, B.S. ’10, received
the 2011 VISTA Award for Teamwork
from the American College of Radiology Imaging Network, for her work on
the RESCUE: Randomized Evaluation
of Patients with Stable Angina Comparing Utilization of Diagnostic Examinations Trial.

In Memoriam

In Memoriam

Alumni

F. ELWOOD DAVIS, J.D. ’43, died from complications from pneumonia,
Jan. 17, 2012. He was 96 years old. A former University trustee, GW
Presidential Medal recipient, and Chair of the Walter A. Bloedorn
Foundation (named after a former dean of the School of Medicine and
Health Sciences), Davis donated more than $2 million to GW and the GW
Medical Center since the late 1970s. Davis earned his law degree at GW in
1943 before becoming an ensign in the U.S. Navy and serving in the Pacific
Theater during World War II. Following his service, Davis worked for Riggs
National Bank and later co-founded the law firm of Reasoner, Davis, and
Vinson. He was general counsel to GW and was noted for his work to gain
home rule for Washington, D.C. In 2002, an endowment from the Davis
family established the F. Elwood and Eleanor Davis Endowed Professorship
at the GW Law School. Davis’ wife of 66 years, Louise Grunwell Davis, died
in 2009. He leaves three children, Robert Davis, Anne Spratt, and Lynne
Whitley; and six grandchildren.

PATRICK C. DIETLER JR., M.D. ’48
JOHN A. DOLAN, M.D. ’61
O. HERMAN DRESKIN, M.D. ’41
LALA M. DUNBAR, M.D., PH.D. ’78
JOHN L. FORD, M.D. ’65
GEORGE M. HENNEBERGER, M.D. ’58
MELISSA A. HYNES, M.D. ’02
JOHN E. KELLY, M.D. ’59
ROBERT L. LARSON, M.D. ’53
CLINTON J. MCGREW, M.D. ’55
ERNEST C. MCKIBBEN, M.D. ’45
JOHN G. MONYAK, M.D. ’52
MATTHEW D. PARRISH, M.D. ’50
JULIUS PIVER, M.D. ’52,
RULON D. ROBISON, M.D. ’59
STANLEY B. ROSENDORF, M.D. ’53
JOHN L. SIDDOWAY, M.D. ’46

New job? Publication? Change of address?

GEORGE A. SOLACK, M.D. ’60

Share your news!
Please send your updates to smhsalumni@gwu.edu
or call (202) 994-7511
or visit www.gwumc.edu/alumni-update
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CHARLES A. STUMP, M.D. ’52
CARLTON E. SWETT, M.D. ’54

Q

NEVILLE I. THROCKMORTON, M.D. ’48
CLIFFORD L. WALKER, M.D. ’45
ELIZABETH ANN ZIMMERMAN, M.D. ’91

FACULTY NEWS

Vascular Disease
Foundation President’s
Award Goes to Sidawy
Anton Sidawy, M.D., M.P.H. ’99,
professor of Surgery in the GW School
of Medicine and Health Sciences
(SMHS), and chair of the Department
of Surgery at the GW Medical
Faculty Associates, received the
Vascular Disease Foundation’s (VDF)
President’s Award for Leadership.
The award was presented at the
foundation’s eighth annual meeting in
Washington, D.C. in September 2011.

Exploring Molecular
Mechanisms to Predict
Neurological and
Psychiatric Diseases

can understand how the nervous sys-

The President’s Award for Leadership

tem establishes stem cells that can

honors Sidawy’s commitment to the

provide for ongoing replacement and

foundation’s mission of increasing

repair, we will be able to create an

awareness of vascular disease and

outline of how one might harness the

improving vascular health.

Anthony-Samuel LaMantia, Ph.D.,

the brain that do not normally regen-

has been recognized by the Vascular

erate or recover after damage.”

Disease Foundation for his leadership

professor in the Department of
Pharmacology and Physiology, and
director of the GW Institute for Neuroscience in the School of Medicine and
Health Sciences received a five-year,
$1.6 million grant from the National

same mechanisms to repair parts of

Stem cells in the embryonic vertebrate olfactory epithelium generate critical peripheral chemosensory
and central neuroendocrine neurons
essential for feeding, social interac-

Institutes of Health to identify molecu-

tions, and reproduction. LaMantia

lar mechanisms that define embryonic

and his colleagues defined these

olfactory epithelium (OE) stem cells.

stem cells over the past several years.

These stem cells, once established in

Nevertheless, the mechanisms for

the developing nose, regulate lifelong

establishing and maintaining these

genesis of olfactory receptor neurons

olfactory epithelial stem cells remain

— the cells that mediate the sense

unknown. Now, GW researchers led

of smell — and are likely pathogenic

by LaMantia will define molecular

targets for neurological and psychi-

mechanisms that are in the network

atric diseases, including Parkinson’s

of genes that are essential for defining

and Alzheimer’s diseases as well as

OE stem cell identity and their abil-

schizophrenia.

ity to make the mature neurons that

“Olfactory epithelial stem cells are
the only neural stem cells in humans

ensure ones sense of smell.
To learn more about the work of

that constantly make new neurons

the GW Institute for Neuroscience,

that make new connections over a

visit www.gwumc.edu/

lifetime,” explains LaMantia. “If we

neuroscience. n

“We are pleased that Dr. Sidawy

and commitment to improving
awareness of vascular disease,”
said Jeffrey S. Akman, M.D. ’81,
G.M.E. ’85, interim vice president for
Health Affairs and dean of SMHS.
“As an academic and a mentor
for the next generation of medical
professionals, Dr. Sidawy’s efforts
educating students, physicians, and
the public about the risks, prevention
and treatment of vascular disease are
remarkable.”
In addition to his academic and
clinical responsibilities at GW, Sidawy
serves as the editor-in-chief of the
Journal of Vascular Surgery and is a
former president of the Society for
Vascular Surgery. Sidawy has been
a member of the board of directors
of VDF since 2003 and served as its
president from 2006 to 2010. n
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Unique Training Program in Transfusion
Medicine and Hematology Established
Naomi L. C. Luban, M.D.,
professor of Pediatrics at
GW’s School of Medicine and
Health Sciences (SMHS), and
division chief of Laboratory
Medicine, Hematology, at
Children’s National Medical
Center (Children’s National),
and Lori Luchtman-Jones,
M.D., associate professor
of Pediatrics, SMHS, and
division chief, Hematology,

Congratulations to
the 2012 “Golden
Apple” Awardees

at Children’s National, have

Congratulations to the 2012 “Golden

secured funding from the

Apple” awardees. The annual awards

National Heart, Lung, and

recognize the contributions of GW

Blood Institute at the National Institutes of Health (NIH) for a new pediatric

School of Medicine and Health Sci-

transfusion medicine and hematology research program with the Children’s

ences (SMHS) professors who have

Research Institute at Children’s National. The program will prepare

made a significant impact on the

candidates for academic leadership and research careers.

students’ education. SMHS students

The program, the Pediatric Hematology and Transfusion Medicine

present the Golden Apples during

Multidisciplinary Research Training Award, will pair faculty and resources

the Medical School Follies, an annual

from SMHS, NIH, the American Red Cross, the U.S. Food and Drug

student talent show.

Administration, and Howard University School of Medicine in an attempt

Each year, first- and second-year

to close a gap in the number of researchers and pediatric subspecialists in

medical students nominate their favor-

hematology and transfusion medicine.

ite professors, while third- and fourth-

The program is designed to encourage diversity among trainees and

year students nominate one resident

will draw upon the strengths of the partnering organizations, including a

and one teaching faculty member. The

wide range of senior mentors, as well as an infrastructure to support trainee

awards are part of the nominating pro-

research from the Clinical and Translational Science Institute at Children’s

cess for the American Medical Student

National. n

Association’s National Golden Apple
Award for Teaching Excellence.

GW Pediatrician van den Anker Receives
2012 Distinguished Researcher Award

This year, first-year students awarded Ron Bohn, Ph.D., associate professor of Anatomy and Cell Biology;
second-year students honored David

John N. van den Anker, M.D., Ph.D., professor of Pediatrics, and of Pharma-

Diemert, M.D., associate research pro-

cology and Physiology, was named the Distinguished Researcher of the Year

fessor of Microbiology, Immunology,

for GW during the 2012 Research Day events. The award is presented annu-

and Tropical Medicine, and associate

ally to honor a member of the faculty for outstanding research achievements

clinical professor of Medicine; third-

as demonstrated by the quality and significance of the faculty member’s

year students selected Chris Bayner,

work and the individual’s track record of biomedical, public health, and health

M.D., a third-year resident in Urology;

services research.

and fourth-year students awarded Jim

A neonatologist and pharmacologist, van den Anker’s research centers

Scott, M.D., professor of Emergency

on the effects of pain medication in premature infants and directs major NIH

Medicine, and of Health Policy, bring-

clinical pharmacology grants. n

ing Scott’s Golden Apple total to 12. n
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Karcher Named President-Elect
of the Association of Pathology Chairs
Donald Karcher, M.D., chair of the Department of Pathology, was chosen to
serve as President-Elect of the Association of Pathology Chairs (APC), the
preeminent organization of academic departments of pathology in the United
States, Canada, and Puerto Rico.
As President of the APC, Karcher will work closely with the leaders of the
other major pathology organizations such as the American Board of Pathology,
the College of American Pathologists, and the American Society for Clinical
Pathology, as well as the Accreditation Council for Graduate Medical Education, Liaison Committee on Medical Education, and the Association of American
Medical Colleges. Karcher’s term as President-Elect begins in July 2012 and he
will become President in 2014. Currently, he serves as Councilor-at-Large.
APC provides leadership and advocacy for the discipline of Pathology and
enables academic departments to meet the demands of its three missions —
medical education, research, and practice. n

Physician Advisor
Named for the Office
of International
Medicine Programs
Jeffrey Berger, M.D., M.B.A., assistant
professor of Anesthesiology and
Critical Care Medicine, has been
appointed physician advisor for
the Office of International Medicine
Programs (IMP). Berger, who also
holds a clinical appointment at the
GW Medical Faculty Associates,
has played an integral part in the
development of the anesthesia
international residency rotation in
Quito, Ecuador. The rotation is the
first to be approved by the American
Board of Anesthesia — paving the
way for other U.S. medical schools to
set up similar international rotations.
Berger will work closely with IMP
to design and implement education
and training programs. He also will
provide guidance and resources to
faculty, students, staff, visitors, and
partner institutions. n

New Smartphone Software Shows
Promise for Diabetes Management
Medicaid provides health care coverage for more than 4 million people
with diabetes — a disease that is often difficult for state programs
to administer because of high patient turnover and challenges with
screening and follow-up.
Given these circumstances, the findings of a demonstration
program titled DC HealthConnect are particularly promising.
Richard Katz, M.D., Bloedorn Professor of Medicine at GW’s
School of Medicine and Health Sciences, director of the Division
of Cardiology at GW’s Medical Faculty Associates, and chair of the
Richard B. and Lynne V. Cheney Cardiovascular Institute, supervised
the 12-month cell phone-based research program that followed 32
patients as a part of the Chronic Care Initiative sponsored by the D.C.
Department of Health.
The program tested the WellDoc DiabetesManager, a softwarebased medical device that uses real-time patient coaching to redefine
conventional diabetes management for people with Type 2 diabetes.
Katz presented the results at the 2011 mHealth Summit in
December and published his findings in the May issue of the Journal
of Health Communications. According to the study, DiabetesManager
reduced ER visits and hospital stays by an average of 58 percent.
These findings demonstrate the significant impact that real-time,
cell phone-based diabetes management can have on a Medicaid
population. n
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Health Sciences’ Rising Star
Debra Herrmann, M.S.H.S., M.P.H., P.A.-C., assistant professor of Physician
Assistant Studies in the GW School of Medicine and Health Sciences (SMHS),
received the 2011 Physician Assistant Education Association (PAEA) Rising
Star Award for her contributions in teaching, research, administration, and
professional service in the area of Physician Assistant (P.A.) education.
“[Herrmann] is truly deserving of the honor because of her dedication to
the educational mission of our program and profession,” said Lisa Alexander,
Ed.D., P.A.-C., interim chair of Physician Assistants Studies. “Her contributions to the P.A. program include revising the curriculum and directing the
rotation for women’s health. She is also very dedicated to her students.
Debra is truly a valued member of the SMHS faculty.”
In addition to her academic role, Herrmann works in the emergency
department at Virginia Hospital Center once a week, serves on the Health
Sciences Curriculum Committee, and Washington, D.C., Mayor Vincent
Gray, B.A. ’64, appointed her to chair the P.A. Advisory Committee to the
D.C. Medical Board. n

continued from page 28
This year, John and Katherine
generously made a half-million dollar
bequest to SMHS, becoming even more
deeply enmeshed in the fabric of GW.
They have also become members of the
University’s Heritage Society, which is a
select group of alumni, friends, faculty
and staff who have supported the
institution through significant planned
giving contributions.
The Pans say the gift is an expression of appreciation toward an institution that has been such a significant
part of both their professional and
personal lives.
“Our social circles and many of our
friends have been from GW because of
John’s practice here,” explains Katherine. “We’ve been a part of GW throughout our professional lives.”
While the Pans didn’t specify a
goal for their gift, they do hope it will
support the principles behind Integrative Health.
To learn more about the Integrative
Medicine Track Program at GW SMHS,
visit: www.gwumc.edu/
trackprogram. n
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New Leadership for Health Sciences
Joseph Bocchino, Ed.D., M.B.A.,
was named interim senior associate
dean of Health Sciences in January 2012. Previously he served as
assistant professor and chair of
GW’s School of Medicine and Health
Sciences (SMHS) Department of
Clinical Research and Leadership.
He also serves as the director of
GW’s new graduate certificate and
Master of Science in Health Sciences (MSHS) in Clinical and Translational Research program, which
was developed in partnership with
Children’s National Medical Center.
This program was established and
supported by the National Institutes
of Health’s Clinical and Translational
Science Award given to GW and
Children’s National.
Bocchino has served as an executive in the pharmaceutical and health
care industries, as well as in the public and private sectors. His corporate
experiences have included: hospital assignments; both domestic markets
and global market assignments; responsibilities in pharmaceutical
clinical research, manufacturing and marketing environments; medical
device development and manufacturing; and oversight responsibilities for
regulatory affairs and product registrations. n

IN DEVELOPMENT

A Heightened Trajectory of GW’s Growth

T

he George Washington University

create endowed professorships allow us to retain

School of Medicine and Health Sci-

and recruit leading physician-scientists and

ences is forging a dynamic vision for

educators for our faculty. Donations to establish

the future. We aim to achieve new

funds that drive biomedical research, clinical

heights of excellence in fulfilling our mission of

enhancement, technology, and scholarships

education, research, and patient care. In leverag-

will heighten the trajectory of GW’s growth.

ing the strengths of our close partnerships with

Donations to existing funds that support these

the George Washington Medical Faculty As-

purposes help us in a similar manner. These

sociates and the George Washington University

examples are a few of the main elements for our

Hospital, we have the elements to attain broader

development efforts now and in the years ahead.

recognition as a great academic medical center.
One fact is clear in surveying the most

We invite you to partner with us in taking
on these ambitious new goals and in garnering

outstanding academic medical centers across the

widespread recognition for GW Medicine. We

country: every great institution has great philan-

look forward to achieving great success with

thropy. Tuition revenue, insurance reimburse-

your help.

ments, and contracts alone will not generate
the resources required to achieve excellence.
Philanthropy provides the needed funds to support breakthrough research, cutting edge clinical
care, and the most modern methods of medical
and health science education.
For that reason, the philanthropic support
of our alumni, grateful patients, and friends has
never had more importance or direct impact on
our mission. For example, contributions that
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A Medical
Education
Makeover
The GW School of Medicine and Health
Sciences (SMHS) recently established an ad hoc
committee of the Curriculum Oversight Group, to
review the school’s medical education curriculum,
as well as examine the curricula of other medical
school. Based on the committee’s feedback
and recommendations, a new curriculum will
be developed for SMHS and is on track to be
implemented in fall 2014. Read More on Page 9

